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Six anti-£^.monoclonal antibodies (mAbs) were
isolated and produced in mouse ascites fluids. Five of
these, one IgM and four IgG2a, were shown by indirect
immunofluorescence, agglutination and capping assays to
bind to amoeba surface antigens. The sixth, an IgG, bound
to an intracellular antigen. Immunoblotting and immuno-
precipitation demonstrated that all of the surface reactive
mAbs recognized the same Mr 48,000 antigen. Treatment with
periodate and Pronase showed that the epitope was
carbohydrate. Metabolic labeling with ^^S-methionine
demonstrated that the antigen molecule also contained amino
acids, thus, was a membrane glycoprotein. All mAbs to the
Mr 48,000 antigen inhibited attack related responses of the
amoeba. It was inferred from this that the Mr 48,000
surface glycoprotein may play an essential role in the
mechanism of E. histolytica attacK on mammalian target cells.
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Entamoeba histolytica is a protozoan parasite that causes
amebiasis in human beings. It is estimated that as many as
400 million people worldwide are infected by this organism.
These infections result in up to 50 million cases of
invasive disease and from 50 - 100 thousand deaths annually
(Walsh, 1986). E. histolytica trophozoites normally live
commensally in the host large intestine. Under conditions
not clearly understood, amoebae invade the intestinal mucosa
causing the intestinal disease. Parasites may also penetrate
into the blood stream and be carried to and invade extra-
intestinal organs, particularly the liver. Amebic liver
abscess is the most frequent cause of death in amebiasis
(Reed and Braude, 1988).
Trophozoites in the intestine may encyst and be
excreted in feces. Transmission of amebiasis occurs when
cysts in contaminated water or food are ingested and excyst
in the intestine of a second host.
Drugs exist which may be used to treat amebic
infections. However, there is no vaccine available which
may be used for immunoprotection against the disease. The
purpose of the research described in this dissertation is to
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identify and characterize £■./iw/o/yhca membrane antigens that
are involved in the mechanism of cytopathogenicity of this
parasite. The information gained will contribute to the
understanding of the molecular pathology of amebiasis and
identification of molecules of potential use in the





Entamoeba histolytica Is a highly motile single celled
amoeboid protozoan. There are a variety of other species
of Entamoeba, but E. histolytica is the only one of clinical
significance in humans (Neal, 1966).
E. histolytica has a simple life cycle. The only host is
the infected human. Trophozoites, the amoeboid vegetative
form of the parasite, most often live commensally in the
host large intestine feeding upon other organisms of the
intestinal flora and digested remnants of food taken in by
the host. Trophozoites are uninucleate, and both the
nucleus and cell divide by binary fission.
Trophozoites in the intestine may encyst. The
conditions that cause encystation in vivo are not known.
Immature cysts are uninucleate, and mature cysts are
tetranucleate (Thepsuparungsikul et al., 1971) The cyst
wall is composed of chitin (Arroyo-Begovich et al., 1980).
Cysts are excreted in feces and may remain viable up
to 2 weeks in a moist environment outside the host (Feachem
et al., 1983). After cysts are ingested, excystation
occurs as they pass through the digestive system.
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Vegetative cells resume growth in the large intestine
of the host (Feachem et al., 1983). Before excystation,
the cyst contains 8 nuclei in a single cell. After
excystation the emerging octanucleate trophozoite undergoes
3 cell divisions before resuming vegetative growth.
E. histolytica grows well in xenic culture in the presence
of bacteria from the intestinal flora (Robinson, 1968).
Diamond and co-workers (1968, 1978) developed a culture
medium for axenic growth of Entamoeba. This important
contribution has made possible the in vitro study of E. histolytica
in the absence of other organisms. E. histolytica trophozoites
do not encyst in laboratory cultures. This has prevented
the study of the complete life cycle of the human parasite
in vitro. However, since only the cyst is infective, this
means that no special safety precautions are reguired to
work with E. histolytica in the laboratory.
The clinical pathology of amebiasis.
Clinical amebiasis occurs when trophozoites living in
the large intestine invade the intestinal mucosa. The
reasons that commensal organisms become virulent are not
clear. There is a large amount of evidence that there are
both virulent and nonvirulent strains of E. histolytica in
nature, both of which can reside in human hosts (Sargeaunt
and Williams, 1978). There is also controversial evidence
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that non-virulent strains can become virulent under the
influence of bacteria in the intestine (Mirelman, 1989).
Invasive colonic amebiasis is characterized by bloody
diarrhea, abdominal pain and fever (Adams and MacLeod,
1977a; Ravdin, 1989). Mucosal ulcerations may be shallow
and nonspecific in morphology or, less frequently, the
classical deep flask-shaped ulcerations that penetrate into
the submucosa (Brandt et al., 1970). Amoebae may penetrate
the intestinal wall, enter the blood stream, and be carried
to and invade extra-intestinal organs, particularly the
liver.
Amebic liver abscess is characterized by fever, right
upper quadrant pain and cavities (Katsenstein et al., 1982;
Adams and MacLeod, 1977b). The abscess is filled with
tissue debris. Amoebae are found only at the periphery of
the abscess (Brandt et al., 1970). Rarely, amoebae may
rupture from the liver and invade nearby tissues, such as
the pleura, lung or pericardium (Adams and MacLeod, 1977b).
Epidemiology of amebiasis.
Amebiasis is prevalent in west and southeast Africa,
south and southeast Asia, Mexico and the western portion of
South America (Walsh, 1984). Amebiasis also is a
significant public health problem in mainland China
(Wang, 1989).
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Amebiasis is often referred to as a "tropical
disease". However, the parasite life cycle does not
require a tropical environment or a non-human host that is
endemic to tropical regions. Amebiasis is actually a
disease caused by poor sanitation conditions, which are the
result of poverty. It is because poverty and the poor
sanitation conditions that accompany it are found mostly in
the less developed tropical regions of the world, that
amebiasis is more prevalent there.
Because of the unique sexual practices of homosexual
men, infection with E. histolytica more common among this
group in developed countries than in the general
population. When fellatio follows anal intercourse, direct
anal to oral transmission of fresh, viable cysts can occur.
Thus, the incidence of non-clinical infection with
E. histolytica xn the United States is greatest in the major
urban areas that are most popular with male homosexuals
(Allason-Jones, et al., 1986). Amebiasis is potentially a
significant opportunistic infection in persons with AIDS,
particularly sexually active homosexual men (Dryden and
Shanson, 1988). However, it is not yet one of the




The most effective way to prevent amebiasis is to
assure good sanitation conditions. In areas where
sanitation is adequate, the incidence of amebiasis is low.
In less developed areas provision of adequate sanitation
conditions requires the elimination of poverty. This will
take time. Meanwhile, clinical means must be available to
protect against and to cure amebiasis.
Several drugs exist which may be used to treat amebic
infections. The most commonly used is metranidazole
(commercial name, Flagyl), one of a group of compounds
called nitroimidazoles (Welch et al., 1978). Metronidazole
is effective against both intestinal and extra-intestinal
infections of E. histolytica. Treatment requires doses of over
1 gram per day for up to 2 weeks. Side effects can be
strong, and there is evidence that nitroimidazoles may be
carcinogenic (McCann and Ames, 1976).
The immunology of amebiasis.
There is some evidence that protective immunity
against E. histolytica d&velops in infected persons. Most
infected individuals become free of the parasite within 6 -
12 months after detection of infection (Nanda et al.,
1984) . While reinfection is common, there is evidence that
some patients who recover from very severe intestinal
amebiasis are immune to reinfection (Deleon, 1970).
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Protective immunity can be induced in experimental
animals immunized with whole E. histolytica extracts (Sepulveda
et al., 1971). However, there has been little progress
toward the development of a vaccine for immunoprotection
against amebiasis in humans. This will require more
knowledge about the immune responses of infected hosts, of
the mechanisms of E. histolytica cytopathology, and of the
molecules involved in the interaction of E. histolytica with
host target tissues. Such molecules may be of use in the
development of a molecular vaccine against amebiasis. The
identification and characterization of E. histolytica proteins
that are involved in the process of attack upon host target
cells was the goal of the research described here.
Mechanisms of mammalian cell attack by E. histolytica.
Destruction of mammalian cells by E. histolytica requires
contact of the parasite with the host target cell surface.
The cellular or molecular mechanisms of E. histolytica attack on
mammalian cells has not been explained. Several recent
reviews have been published on this subject (Ravdin, 1989;
Ravdin, 1988; Young and Kohn, 1987; Petri and Ravdin,
1987) .
The target cell attack mechanism has been proposed to
consist of three separate events: receptor mediated
adherence of the amoeba to the target cell; lysis of the
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target cell; and phagocytosis of the target cell or its
remnants (Ravdin et al., 1980).
The relative importance of mechanical (phagocytic) and
of chemical (lysing molecules) factors in the killing
mechanism has not been determined. However, most
investigators assume that chemical lysis of the target cell
membrane is the critical event of target killing.
Several mechanisms to explain target cell lysis have
been proposed. These included lysis by secreted hydrolytic
enzymes or by a secreted pore forming protein.
£■./iwfo/yhca trophozoites contain potent sulfhydryl type
protease activities. Lushbaugh et al. (1985) showed that
extracts from E. histolytica caused release of tissue culture
cells from their substratum, but did not lyse the cells.
This so-called "cytopathic effect" was inhibited by serum
proteins. They later purified a neutral cathepsin B-like
protease activity tram E. histolytica, which had the same effect
as cell extracts (Lushbaugh et al., 1987) . Gadasi and
Kessler (1983) demonstrated a secreted protease activity
that was capable of hydrolyzing collagen. Alvila et al
(1985) provided the first evidence that essentially all
E. histolytica protease activity is inhibited by cysteine
protease inhibitors. Keene et al. (1986) purified the
major protease of E. histolytica. They found this to have a Mr
of 56,000 and be of the cysteine family. More recently,
Luaces and Barrett (1988) reported purification of a
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cysteine protease of Mr 29,000, which they believed to
represent the major protease of E. histolytica. This enzyme
degraded basement membrane collagen and released cultured
cells from their substratum. Becker et al. (1988) reported
that the addition of cysteine protease inhibitors with
infecting amoebae did not prevent the formation of lesions
in experimental animals and concluded that protease
activity was not essential for the tissue invasion process.
The role of secreted proteases in the cytopathology of
E. histolytica is not yet clear. At this time, it seems most
likely that the secreted proteases play a role in the
destruction of extracellular matrix in E. histolytica tissue
invasion rather than in actual contact lysis of host cells.
.■4-9 •
A membrane associated, Ca dependent phospholipase A has
been described in E. histolytica (Long-Krug, et al., 1985). It
is proposed to act by disrupting target cell membrane
lipids, thus causing the target cell to lyse. There has
been no confirming evidence or further exploration of this
notion.
Two laboratories have described a pore forming protein
produced by E. histolytica which may be secreted under certain
circumstances (Young and Cohn 1985, Lynch et al., 1982).
There has been no work on the characterization or role of a
pore forming protein since its original description. It
remains a potential factor in the mechanism of attack.
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There is one report that pretreatment of amoebae with
a phorbol ester, an activator of protein kinase C,
stimulated amoeba killing of target cells (Weikel et al.,
1988) . This suggests that a phosphoinositide based
transmembrane signaling mechanism operates in E. histolytica, a
primitive metazoan organism, and that this signal
transduction is involved in the attack mechanism.
Similarly, a role for Ca"*"^ in E. histolytica target cell
destruction has been suggested by observations that Ca"^^
antagonists inhibit target cell killing (Ravdin et al.,
1985; Ravdin et al., 1982). Using the fluorescent Ca'*'^
probe, Fura-2, and fluorescence microscopy with digitized
image analysis, an influx of extracellular Ca"^^ into a
target cell following contact by an amoeba trophozoite was
demonstrated. This observation verified that the target
cell is lysed following contact, but gave no evidence for a
role of Ca'*'^ in the process. There was no detectable
change in intracellular free Ca"*"^ in the amoeba during the
attack. Therefore, a role of Ca'*’^ in the killing mechanism
remains to be established.
The mechanism of £./iw/o/yft'ca destruction of host cells,
has often been compared to that of killer cells of the
immune system of eucaryotes. This thinking lends non-
experimental support to the concept of a "lethal hit"
chemical mechanism of target membrane lysis (Ravdin, 1989),
which is believed to occur with cytotoxic lymphocytes.
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However, there is a fundamental difference in the goal of a
cytotoxic lymphocyte and an amoeba parasite in attacking a
mammalian cell. Immune cells kill foreign cells to protect
the host. Amoebae kill foreign cells to eat them. Target
cell ingestion is a goal of E. histolytica, but not of killer
lymphocytes. Therefore, phagocytosis should be considered
an integral part of the attack mechanism by E. histolytica.
All events of E. histolytica target cell interaction are
blocked by cytochalasins, demonstrating that involvement of
the actin cytoskeleton is essential for all stages of the
attack mechanism (Bailey et al., 1985). There is also
direct evidence that phagocytic activity is essential for
the virulence of E. histolytica. Mutant strains deficient in
phagocytic activity were also less virulent than wild type
strains when injected into experimental animals (Rodriguez
and Orozco, 1986). Bailey et al. (1985, 1987) showed that
phagocytosis was initiated immediately upon contact with a
variety of mammalian target cells in vitro. This response was
accompanied by rapid polymerization of amoeba actin and
occurred with a variety of mammalian cell challenge models
(Bailey et al, 1987), but not with noncellular particles
such as latex beads (Bailey et al, 1985) or bacteria
(Bailey, unpublished observation). These results indicated
that phagocytosis was an immediate and probably receptor
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mediated response to contact with target cells and was not
separated temporally from other events of the killing
process.
Molecules involved in the interaction of E. hLstolvtica
with target cells.
E. histolytica trophozoites are believed to adhere to
target cells by binding of one or more amoeba surface
lectins to target cell membrane carbohydrate ligands.
Original evidence for this was based on studies of the
ability of sugars to inhibit amoeba target cell attachment.
On the basis of sugar inhibition of E. histolytica binding and
killing of various target cell models, N-acetylglucosamine
(GlcNAc) (Kobiler and Mirelman, 1981) and galactose (Gal)
or N-acetylgalactosamine (GalNAc) (Petri et al., 1987) have
been proposed as specific target ligands.
The disaccharides, lactose (Lac) (Cano-Mancera and
Lopez-Revilla, 1987), lactosamine (LacNAc) (Li et al.,
1988) and oligomers of GlcNAc, chitobiose and chitotriose
(Kobiler and Mirelman, 1981) have also been shown to
inhibit E. histolytica hindinq to target cells. Lac and LAcNAc
inhibit more strongly than do monosaccharides, suggesting
that the amoeba lectin(s) recognize a more complex
carbohydrate structure than a single monosaccharide. Two
glycoproteins, asialofetuin and asialoorsomucoid inhibit
more effectively than any of the free sugars tested.
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There has been some progress in identifying amoeba
surface lectins that may be involved in target cell
attachment. Petri et al. (1987) purified a 170 kD protein
by affinity chromatography using asialorosomucoid.
Subsequently, using mAb against the 170 Kd peptide, they
purified a 260 kD protein comprised of a 170 kD and a 35 kD
subunit (1989). The purified protein inhibited E. histolytica
binding to the Chinese hamster ovary (CHO) target cells.
Rozales-Encina and co-workers (1987) reported
isolation of a 220 kD lectin from E. histolytica vxt-h.
specificity for oligomers of GlcNAc (e.g., chitotriose).
This protein agglutinated human erythrocytes and inhibited
E. histolytica binding to Madin-Darby canine kidney (MDCK)
cells, another amoeba target cell model (Meza et al.,
1987) .
Other studies have sought to identify the carbohydrate
structures on target cells that are recognized by
E. histolytica. Thus, Li et al. (1988) compared adherence of
/iw/o/yh'ca trophozoites to a panel of variant CHO cell lines
that have defined alterations in their membrane
glycoprotein glycosylation patterns (Li et al., 1988).
They found that one variant, which was deficient in
membrane sialic acid and, therefore, had an increased
proportion of terminal Gal residues, bound more
trophozoites than wild type cells. Variants that were
deficient in both terminal sialic acid and terminal Gal,
15
and consequently had more GlcNAc termini, bound less
amoebae than wild type. Variants with a diminished number
of surface glycan chains, because they lacked all Asn
linked membrane glycans, also were less effective. The
conclusion from these studies was that E. histolytica recognized
Asn bound glycans with a terminal Gal residue best. In a
more recent study Li et al. (1989) found a correlation of
CHO surface glycan structure with lytic activity.
Bailey and co-workers have sought the identity of
mammalian cell surface molecules that stimulate E. histolytica
attack. They found that protein-free liposomes prepared
from erythrocyte membranes stimulated the same
polymerization of amoeba actin as did whole target cells
(Bailey et al., 1987). Using synthetic liposomes
constructed of phospholipids and individual purified
glycosphingolipids from erythrocyte membranes, this
laboratory has shown that neutral glycosphingolipids
containing a Gal /31-4 GlcNAc- (LacNAc) have the greatest
stimulatory effect (Bailey et al. 1987a). The most active
glycosphingolipid was paragloboside (Gal )31-4 GlcNAc )01-3
Gal ^1-4 Glc /31-Ceramide) . Liposomes constructed with
GlcNAc )31-3 Gal /31-4 Glc )01-Ceramide (paragloboside from
which the terminal Gal has been removed with /3-
galactosidase) had completely lost their stimulatory
activity (Bailey et al., 1989). Liposomes constructed with
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neutral glycosphingolipids bearing GalNAc, Gal al-4(3)-
teirmini and gangliosides, which bear sialic acid termini,
were much less effective or inactive. This indicated that
E. histolytica responded best to terminal Gal )91-4 residues.
Stimulation of polymerization of amoeba actin by
target cell membrane lipid liposomes and synthetic
liposomes constructed with stimulatory glycosphingolipids
was inhibited by the same sugars and glycoproteins, and in
the same relative order, as was interaction of E. histolytica
with live target cells (Bailey et al., 1987a) This implies
that the liposome stimulated cytoskeleton response involves
interaction of the same molecules on the amoeba and
noncellular target model as interact in attack of the
parasite on a live target cell.
Two observations suggest that binding of the amoeba
lectin to its target cell carbohydrate ligand is not
sufficient to initiate the attack response by the parasite,
and, therefore that additional amoeba or target membrane
molecules are involved in this mechanism. First, liposomes
lacking a negatively charged phospholipid failed to
stimulate amoeba actin polymerization and phagocytosis
(Bailey et al., 1987). Furthermore, latex beads covalently
conjugated with asialofetuin, a Gal (/31-4) GlcNAc- bearing
glycoprotein that inhibits E. histolytica interaction with whole
target cells and membrane liposomes, failed to stimulate
the cytoskeleton response, even though these beads were
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phagocytized at a greater rate than unconjugated beads and
beads conjugated with glycoproteins lacking the terminal
Gal (Bailey et al., 1989). Thus, additional target cell
components, possibly including negatively charged
phospholipids or other non-glycolipid structures of the
membrane bilayer may to be essential to trigger the
destructive attack by the parasite.
In summary, actin polymerization is the first
detectable molecular response by E. histolytica following
contact with a target cell, and this cytoskeleton
activation is essential for target killing. The actin
response stimulated by liposomes bearing appropriate
glycosphingolipids and phospholipids appears identical to
that stimulated by whole target cells. Stimulatory
liposomes provide a convenient noncellular model with which
to study the biochemical mechanism of host target cell
attack by this pathogen and to identify the parasite and
target molecules involved in this process. For this
reason, inhibition of liposome stimulated amoeba actin
polymerization was chosen for the present research as a
means to identify attack related mAb.
Research objectives.
The long term goal of this research is to utilize
monoclonal antibodies to identify and characterize E.
histolytica surface antigens that are involved in the molecular
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mechanism of cytopathogenicity of this parasite. The
information gained will contribute to the understanding of
the mechanism of E. histolytica cytopathogenicity and may
identify proteins of E. histolytica of utility in the search for
a vaccine against amebiasis.
The specific objectives of this project were to:
1. Develop immunological assays to detect mAbs
against E. histolytica surface antigens and to assess
the ability of such antibodies to inhibit interaction
of E. histolyticawith target cell membrane
liposomes.
2. Prepare a battery of monoclonal antibodies
and identify those with the above properties.
3. Produce large quantities of the selected monoclonal
antibodies in mouse ascites fluids.
4. Characterize the selected monoclonal antibodies.
5. Identify and characterize the amoeba antigens
recognized by the selected monoclonal antibodies.
Experimental plan
Rabbit antiserum was prepared against whole E. histolytica
and used to develop itiAb screening assays. This antiserum
was also used to determine if it was possible to detect
antibody inhibition of mammalian target cell binding to
amoebae and target membrane liposome stimulated amoeba
actin polymerization. Human RBC were used as the target
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cell model, and liposomes prepared from lipids of the RBC
membrane were used as the liposome stimulus.
Following immunization of mice with whole amoebae and
fusion with myeloma cells, hybridoma supernatants were
screened by ELISA to detect all clones producing antibodies
against E. histolytica. Positive clones were then screened by
an indirect immunofluorescence assay to detect antibodies
directed against amoeba surface antigens. The selected
hybridomas were purified by recloning. Monoclonal
antibodies with the desired properties were produced from
these clones in mouse ascites fluids. The ascites fluids
were then assessed for their ability to block RBC membrane
liposome stimulated actin polymerization. The selected
mAbs were characterized in terms of isotype by ELISA. The
cellular location of bound antigens was determined by
immunofluorescent cytochemistry. Cross reactivity with
antigens of other species was assessed by indirect
immunofluorescence and immunoblotting.
Immunoblotting and immunoprecipitation experiments
were conducted to determine the molecular size and number
of proteins recognized by the anti/iwtofyhcamAbs.
Selective destruction of carbohydrate and protein structure
was used to determine the chemical nature of the epitopes
of the mAbs. Immunofluorescence cytochemistry was used to
determine the cellular distribution of the amoeba antigens




A description, including the commercial source of all
chemicals, biological reagents and equipment used in this
research, is given where that substance or item is first
referred to in the text of this dissertation.
Methods.
Amoeba cultivation.
Entamoeba histolytica, strain HMl-IMSS, was used in this
investigation. The culture maintained in our laboratory
was originally obtained from the American Type Culture
Collection. Amoeba trophozoites were grown axenically in
16 X 125 mm screw-capped glass tubes at 37°C using
Diamond's TYI-S medium (Diamond et al. 1978), supplemented
with 12.5% bovine serum (Biofluids, Inc., Rockville, MD).
Larger quantities of amoeba were produced by culturing in
flat, 50 ml plastic tissue culture flasks (Nunc,
Copenhagen, Denmark). Trophozoites were harvested in mid¬
log phase by chilling for 5 m to facilitate release of
amoebae from the culture vessel wall and centrifugation at
200 X g for 2 m.
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Preparation of amoebae plasma membranes.
The method described by Aley et al. (1980) was
employed with some modification. Amoebae were harvested,
washed twice with 19 mM potassium phosphate-saline (PBS),
pH 7.2 and then resuspend at 2 x 10^ cells/ml in the same
solution plus 10 mM MgCl2. An equal volume of PBS
containing 1 mg/ml concanavalin A was then added with
gentle mixing to agglutinate the amoebae. After 5 m the
cells were collected by centrifugation at 50 x g for 1 m
and resuspended in 10 ml of hypotonic lysis buffer
containing 10 mM Tris, pH 7.5, plus the amoeba protease
inhibitors, 2 mM iodoacetamide (lAA), 0.5 mM N-tosyl-1-
lysine chloromethyl ketone (TLCK) and 2 mM
diisopropylfluorophosphate (DIFP). The cells were allowed
to swell for 10 m and then were homogenized by 40 cycles in
a type B glass Bounce homogenizer.
The homogenate was layered on top of a discontinuous
sucrose gradient consisting of 2 ml each 60% sucrose, 20%
sucrose, 0.5 M mannitol in 10 mM Tris, pH 7.5. Seven ml of
homogenate was layered on the top and centrifuged at 250 x
g in a swinging bucket rotor for 1 h at room temperature.
The plasma membrane rich fraction, which rested on the 60 %
sucrose face, was collected, washed and resuspended in 1 ml
of 1 M a-methyl mannoside to release membrane bound
concanavalin A. The membranes were then washed 3 times
with 10 mM Tris, pH 7.5 plus 1 mM Mg2Cl and the above
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protease inhibitors. The presence of membrane leaflets was
confirmed by DIG microscopy. This membrane rich fraction
was stored at -85°C and used as one of the test immunogens
to generate E. histolytica membrane specific antibodies.
Preparation of human red blood cell membrane lipids.
Outdated human type A (+) blood was obtained from the
local American Red Cross. The red blood cells (RBC) were
collected by centrifugation at 1000 X g and washed 3 times
with cold PBS, pH 6.3. RBC membranes (ghosts) were
prepared by hypotonic lysis of packed RBC in a 40-volume
excess of 5 mM Na2HP04, pH 8. The lysing buffer was added
rapidly to the cell pellet and vortexed. After 5 m the
membranes were washed 3 times with 20-fold diluted PBS.
To destroy membrane proteins, the washed ghosts were
suspended in 5 volumes of 150 mM NaCl, 5 mM CaCl2. One mg
Pronase (Boeringher-Mannheim Biochemicals, Indianapolis,
IN) was added per ml, and the membrane suspension was
sonicated in ice for 1 m then incubated at 37°C for 2 h.
Following incubation the protein depleted membrane
fragments were washed 2 times with PBS and lyophilized.
This treatment totally destroys membrane proteins (Bailey
et al., 1987).
Total membrane lipids were isolated by two extractions
with chloroform:methanol (2:1, v/v) of the lyophilized,
pronase treated membrane fragments. Each extraction volume
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was equal to the volume of packed membranes before
lyophilization. The combined extracts were filtered to
remove insoluble material, dried under air at 45°C to a
constant weight, and redissolved in chloroform:methanol
equal to the volume of packed membrane fragments before
lyophilization. The final extract was stored at 4°C in a
tightly sealed dark bottle. The yield was approximately 5
mg of lipid per ml of packed membranes.
Preparation of RBC membrane lipid liposomes.
Multi-laminar lipid vesicles (liposomes) of the
extracted RBC membrane lipids were prepared by sonication
of dried lipid films in PBS, pH 6.3. Dissolved lipids in
chloroform:methanol were dried under air in a small glass
tube at 45°C. PBS, pH 6.3 equal to the volume of
chloroform:methanol was added and the mixture was sonicated
for 2 m in ice. This produced a stable suspension of multi-
laminar vesicles mostly on the order of 1 - 3 jum in
diameter.
Stimulation of E. histolytica actin polymerization by RBC and
liposomes prepared from RBC membrane lipids.
The methods developed by Bailey and co-workers (1985,
1987) were used. E. histolytica trophozoites were harvested,
washed twice and resuspended in PBS, pH 6.3 containing 2 iiiM
MgCl2 and 8 mM CaCl2 at a concentration of 2 x 10®
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cells/ml. One hundred ^il of the amoeba suspension was
added to wells of a conical bottom 96-well plate and
incubated at 25°C for 5 m. The amoebae were then
challenged with 10 /il of whole RBC (10^ RBC) or 10 nl of
RBC membrane liposomes prepared as described above. The
mixed cell suspension was agitated gently initially and at
30 second intervals to allow free interaction of the
amoebae with the challenge particles. Amoebae were
incubated with whole cells for 4 m and with liposomes for
90 s. Interaction was terminated and cells fixed by
addition of 100 jul of 2.5 % glutaraldehyde. Twenty seconds
later 20 /il of 10% Triton X-100 in PBS 6.3 was added with
mixing to permeate the amoeba membranes. After 5 m, the
cells were washed 3 times by centrifugation at 150 x g for
1 m in PBS, pH 6.3 containing 0.1% bovine serum albumin
(BSA). With this low g force, few of the unattached RBC
sedimented, and they were removed with the supernatant wash
fluid.
After washing, the cells were resuspended in 50 jul
PBS, pH 7.4 and stained for 10 m with 3.3 Rhodamine-
Phallodin (Molecular Probes, Eugene, OR). The percentage
of cells responding to the whole target cell or liposome
challenge was determined by counting 100 cells in randomly
selected fields under the fluorescence microscope following
the criteria described by Bailey et al. (1987).
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Rabbit immunization.
An adult, male New Zealand White rabbit was used.
Prior to immunization, approximately 10 ml of blood was
drawn from an ear vein. The blood was allowed to clot
overnight and then centrifuged at 2,500 x g for 10 m to
separate the serum. The preimmune serum was separated in 1
ml aliquots and stored at -85°C until used.
The rabbit was immunized with three injections of
whole /iwto/yhca trophozoites given at 1-week intervals.
The first injection contained 10® amoebae and was prepared
in complete Freund's adjuvant as follows: The amoebae were
suspended at 2 x 10®/ml in saline. They were then mixed
with an equal volume of complete Freund's adjuvant and
placed in a multichamber churn (Becton Dickinson,
Rutherford, NJ). The suspension was churned until the
emulsion did not separate when a drop was placed in water.
The emulsified antigen was administered subcutaneously.
The second and third injections contained the same antigen
dose, but were prepared in incomplete Freund's adjuvant and
were administered by intramuscular injection.
Blood was drawn four weeks after the first injection
and the Ab titer was measured by ELISA. A final injection
of half of the original dose in saline was given then.
The rabbit was bled from an ear vein 8 days later, and the




Eight-week old female Balb/c mice (Charles River,
Wilmington, MA) were used for immunization to prepare
hybridomas. The mice were separated into three groups of 6
mice each. Prior to immunization, blood was collected from
the caudal vein of each mouse. The serum was collected and
saved for later use at -20°C as described above.
The first group of mice was immunized with whole
/iwto/yh'cfl trophozoites suspended in saline. The second
group was injected with whole amoebae mixed with complete
Freund's adjuvant. The third group was injected with the
amoeba membrane-rich fraction mixed with complete Freund's.
A mouse from the group with the most effective immunization
procedure was to be used for fusion with myeloma cells.
For the first group of mice, harvested trophozoites
were washed three times and resuspended in saline at 5 x
10® cells/ml. Mice were injected intraperitoneally with 0.1
ml of this suspension (5 x 10® amoebae). For the second
group of mice the trophozoites were first suspended in
saline at a concentration of 5 x 10®/ml, then emulsified as
described above after addition of an equal volume of
complete Freund's adjuvant. Mice in the third group were
injected with the amoeba membrane-rich fraction (50 /xg
total protein/mouse) in complete Freund's.
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All injections were administered intraperitoneally.
Similar injections were given two and four weeks after the
first. Cell fusion was performed six weeks after the first
immunization. Four days before fusion, the mice were given
an intravenous injection at one-half the dose of the first
immunization. Sera were taken after three weeks and again
one day before fusion to determine the antibody titers by
ELISA. The spleen cells from the mouse with the highest
titer were used for fusion with myeloma cells.
Production of hvbridomas.
Hybridomas were produced in the laboratories of the
Immunology Branch of the Division of Host Factors, Center
for Infectious Disease, Centers for Disease Control
(CDC),with assistance from CDC staff. The overall protocol
and stages of hybridoma and monoclonal antibody production
are outlined in Fig. 1.
Cell fusions were performed according to the procedure
of Kohler and Milstein 1975) with some modification.
Spleen cells (2 x 10®) from the immunized mouse and Sp2/0
myeloma cells (1 x 10®) were fused for 45 second using
preheated polyethylene glycol-4000. After fusion, the cell
suspension was diluted by dropwise addition of 10 ml of
base medium over 3 m and then further diluted with 40 ml of
base medium. Feeder cells (2.5 x 10^ spleen cells from the
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donor mouse) were added, and the total suspension was
centrifuged at 300 x g for 10 m.
The cells were resuspended at 5 x 10^ cells/ml in a
hybridization medium consisting of reinforced minimum
Eagle's medium (RMEM) containing 10 nK hypoxanthine (H),
0.4 iM aminopterin (A), 16 /xM thymidine (T) , 20% fetal calf
serum and 50 /xM )9-mercaptoethanol (HAT medium) . The fusion
cell suspension was dispensed into seven 24-well tissue
culture plates at 1 ml/well and incubated at 37°C in a 6%
CO2 atmosphere. After 5 days the wells were replenished
with new HAT medium. The seventh day after fusion, aliquots
of the hybridoma supernatant fluids were taken for screening
for mAbs by ELISA. The wells were replenished at this time
with RMEM supplemented with H and T. Positive cultures were
recloned by limiting dilution to a calculated concentration
of 2 cells/ml, and 250 nl was added to each well of one 96-
well plate.
Supernatant fluid from wells exhibiting a single clone
were selected for further testing. After the second
screening of the recloned hybridomas, 5-10 selected
hybridoma clones were expanded by culture in 150 ml flasks.
A portion of the cells was cryopreserved. Another was used
for large scale production of mAbs in mice.
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Production of monoclonal antibodies in mice.
Mice were primed by intraperitoneal injection of 0.6 ml
of Pristane (2,6,10,14 tetramethyl pentadecane. Sigma) at
least 10 days before injection intraperitoneally with 1 x
10® hybridoma cells. When ascites fluid accumulation was
obvious from abdominal swelling, the peritoneal cavity was
punctured with an 18 gauge needle and the fluid aspirated.
After clotting for 24 h at room temperature, the serum was
removed and cleared of fat and insoluble material by
centrifugation at 10,000 rpm for 30 minutes. Clarified
ascites fluid between the floating lipid layer and the
pellet was removed by aspiration and frozen in aliguots at
-85°C. For a secondary production of ascites, 0.1 ml of
fresh ascites fluid was injected intraperitoneally into
additional Pristane primed mice.
Monoclonal antibody screening assays.
Three types of screening assays were used. These were
established using both rabbit and mouse antisera. The
methods are described as used for mAbs, but were the same
for antisera. The initial screening for anti-E./ityto/yft'ca mAb
production by hybridoma cultures was by ELISA. An
immunofluorescence assay (IFA) was then used to detect
antibodies against amoeba surface antigens. Finally, a
"blocking” assay, which depended upon the ability of mAbs to
inhibit RBC membrane liposome stimulated polymerization of
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amoeba actin (Bailey et al. 1987), was used to detect
antibodies capable of inhibiting liposome stimulated
E. histolytica actin polymerization or attachment of RBC to
amoeba trophozoites.
ELISA assay.
/listo/yhca trophozoites were harvested, washed, and then
resuspended in 0.15 M borate-75mM saline, pH 8.5 (BS)
containing 5mM lAA, 0.2 mM TLCK and 2mM DIFP. The
suspension was sonicated for two minutes in ice, and the
sonicate clarified by centrifugation at 40,000 x g for 30 m.
The protein concentration of the sonicate supernatant was
adjusted to 150 /xg/ml, and 100 /il was added to each well of
several 96-well ELISA plates (Corning Glass Works, Corning,
NY). The plates were sealed with parafilm and incubated
overnight at 4°C (Torian et al., 1987).
To conduct ELISA assays, the lysate was decanted, the
wells washed 3 times, and BS buffer containing 1% BSA was
added to block nonspecific protein binding sites. After 1 h
at room temperature, the wells were washed three times with
BS containing 0.05% Tween 20.
Serial dilutions of ascites fluid or hybridoma culture
supernatant were added to wells (100 jul/well) for 2 h at
room temperature. After washing 3 times with BS plus 0.05%
Tween 20, 100 /nl anti-mouse IgG or IgM (Zymed) , conjugated
with alkaline phosphatase (AP, Sigma, diluted 1:1000), was
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added to each well and incubated for 4 h at room
temperature. The wells were washed again 4 times with BS
plus 0.05% Tween 20, and then 100 ^il of commercial alkaline
phosphatase substrate (PNPP, Zymed, South San Francisco, CA)
was added to each well. The plates were then incubated at
37°C and monitored for color development. The reaction was
stopped by addition of 50 /xl of 6 N NaOH when observable
color had developed in a representative number of wells.
Incubation time did not exceed 15 m.
The color produced was quantity with an ELISA reader
(Titertek Multiskan MCC/340, Flow Laboratories, McLean, VA)
at 405 nm using a well from which the primary antibody or
amoeba lysate had been omitted as the blank. Immune and
non-immune polyclonal mouse sera diluted 1:25 were used as
positive and negative controls for each plate.
Indirect immunofIncrescent assay fIFA).
E. histolytica trophozoites were washed and suspended in
PBS, pH 6.3, at 10® cells/ml, and then fixed by addition of
an equal volume of 7% formaldehyde for 45 m. After washing
3 times with PBS, pH 7.4, the amoebae were suspended at 2 x
10® cells/ml in PBS, pH 7.4 containing 0.1% BSA. A 50 /xl
aliquot of cell suspension was transferred into each well of
a conical bottom 96-well plate. Fifty /xl of primary
antibody (antiserum, hybridoma supernatant or ascites
fluid), diluted as required in PBS, pH 7.4, 10% normal goat
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serum, 0.1% BSA, was added and incubated with the cells for
2 h with resuspension every 5 m. The cells were washed by
centrifugation in the conical well plates using PBS-BSA and
then suspended in this buffer containing a 1:50 dilution of
fluorescein labeled goat anti-mouse IgG or IgM (Zymed),
diluted in PBS, pH 7.4, 10% normal goat serum, 0.1% BSA, for
2 h at 37°C. After washing with PBS, the cells were
suspended in 50 ^i'\. of 50% glycerol in PBS, pH 7.4. Fifteen
/ill of the immunofluorescently stained cell suspension was
mounted on a microscope slide, and the coverslip was sealed
with clear nail polish.
To distinguish between surface bound fluorescence and
binding of fluorescent antibody to intracellular antigens,
the IFA was run in the same way, except that cells were
incubated with PBS containing 0.1% BSA and 1% Triton X-100
after fixation and the first wash. This made the surface
membrane permeable to primary and secondary antibodies so
that internal antigens would be stained.
Antibody inhibition of liposome stimulated E./iisfo/vtica act in
polymerization and RBC attachment.
This was done by the same procedure described above for
stimulation of amoeba actin polymerization, with the
following modifications. Fifty jul of the amoeba suspension
was added into the wells of a conical bottom 96-well plate
and incubated at 25°C for 5 m. Then, 50 /xl of different
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dilutions of normal serum, antiserum to E. histolytica or ascites
fluid were added and incubated for a further 15 m. The
amoebae were then challenged with 10 nl of whole RBC (10^
RBC) or membrane liposomes. Further steps were as
described.
Monoclonal antibody isotvpina.
Immunoglobulin G itiAb isotypes were determined by ELISA
using monoAb - ID EIA Kits (Zymed). The ELISA procedure was
followed with the following modifications. Plates were
coated first with ascites fluid diluted 1:100 with PBS, pH
7.4. Isotyping antisera were used as the primary antibody
following the suppliers instructions. Alkaline phosphatase
conjugated anti-Ig isotype sera were used as secondary
antibodies following the suppliers procedure.
Treatment with Pronase and periodate.
E. histolytica coll lysate (approximately 2.5 mg protein/ml)
was prepared by 2 m sonication of washed cells in ice and
divided into 2 equal portions. One portion was treated with
2mg/ml Pronase (Calbiochem-Behring Corp, La Jolla, CA) at
37°C for 2 h, then used to coat wells of 96-well plates.
SDS PAGE gels of E. histolytica lysates treated in this way
showed no bands detectable by Coomasie blue.
The second portion of lysate was used to coat plates as
described above, before periodate treatment. Wells were
treated with freshly prepared 20 mM sodium periodate in 50
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mM sodium acetate, pH 4.5, for 1 h at room temperature in
the dark. The wells were rinsed with 50 mM sodium acetate
then incubated with 50 mM sodium borohydride in PBS, pH 7.4,
for 30 m at 23°C to destroy free aldehyde groups.
Thereafter, all wells were washed, blocked with BSA, and
processed further for ELISA as described above.
Electrophoresis.
Discontinuous polyacrylamide gel electrophoresis (PAGE)
was done using the Hoefer vertical slab gel, SE 600, and
Mighty Small, SE 250, units. Both 7% and 10% crosslinking
gels were used. Most often the reducing sodium
dodecylsulfate (SDS) PAGE method of Laemmli (1970) was used.
Reducing, non-reducing and native gels were run. For non¬
reducing gels mercaptoethanol was omitted. For native gels,
both mercaptoethanol and SDS were omitted. Gels were
stained with Coomasie blue to visualize the protein bands.
Relative molecular size (Mr) of proteins was determined
using commercial molecular weight standards. The following
standards were used: myosin, Mr 205,000; /3-galactosidase, Mr
116,000; phosphorylase, Mr 97,000; BSA; Mr 68,000; glutamate
dehydrogenase, Mr 55,000; egg albumin, Mr 43,000; lactate
dehydrogenase, Mr 36,000; bovine carbonic anhydrase, Mr
29,000 and trypsin inhibitor Mr 20,400. These were obtained
from Sigma and Diversified Biotech, Inc., Newton, MA. The
Mr values of unknown polypeptides were estimated using a
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linear regression equation derived from the migration on SDS
PAGE of the above standards (Jones, 1969) and the computer
program Enzfitter (Elsevier).
Isoelectric focusing.
Isoelectric focusing was accomplished using a Hoefer
Rotophor apparatus. Amoebae (2 x 10® cells) in log phase
were washed 3 times with PBS, pH 6.3, in the presence of
protease inhibitors. The amoeba pellet was lysed in 2 ml of
isofocusing sample buffer (10% Triton X-100, 2% ampholytes
(Pharmacia/LKB, pH 3.5 - 9) plus protease inhibitors) by
vortexing for 2 m in ice. The lysate was centrifuged at
40,000 X g for 30 m. The supernatant was collected and
diluted to 40 ml with sample buffer loaded into Rotofor
chambers as described by the manufacturer. Focusing was
done at 12 watts for 5 h with cooling to 4°C. The total
volume from each chamber (approximately 2 ml) was collected,
the pH of each fraction was measured, and fractions were
stored at -85 °C for further analysis by SDS PAGE and
immunoblotting.
Immunoblottina.
Transfer of proteins from polyacrylamide gels to
nitrocellulose paper (Hoefer) and immunoblotting procedures
followed the method of Towbin et al. (1979) using both the
Hoefer wet transfer apparatus and the ABN Polyblot semi-dry
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transfer apparatus (Fisher Scientific). Following transfer,
the nitrocellulose sheets were washed for 1 h with 3 changes
in 50 inM Tris, pH 7.4, 150 mM NaCl, 0.05% Tween 20.
Nonspecific binding sites were blocked by soaking membranes
overnight with 3% BSA (RIA grade,Sigma) in 0.05 M Tris-HCl,
0.2 M NaCl and 0.1% Tween 20. The blocked membranes were
again washed as above and then incubated with appropriately
diluted primary antibody for 1 h at room temperature, and
washed again.
For detection of IgM primary antibodies the membranes
were incubated with either horse radish peroxidase (HRP) or
alkaline phosphatase (AP) linked anti-mouse IgM (Zymed,
diluted 1:5000) for 1 h. After washing substrate was added.
For HRP, 3, 3'-diaminobenzidine (5 mg/ml in 50 mM Tris, pH
7.4) plus 6.5 jul of H2O2 was used; for AP, the substrate was
/7-nitrophenyl phosphate. The enzyme reaction was stopped by
washing membranes with water. For detection of IgG primary
antibodies, membranes were incubated with ^^^I-Protein G
(5 X 10^ cpm/ml in PBS, pH 4.5) for 1 h. Membranes were
washed exhaustively, dried and prepared for autoradiography.
Radioiodination.
Surface membrane proteins of live E. histolytica
trophozoites were labeled with ^25^ using the
lactoperoxidase - glucose oxidase method (Schmidt et al.,
1972). Amoeba were harvested, washed with PBS, pH 6.3, and
38
suspended in this buffer containing 100 inM glucose at 2 x
10^ cells/ml. After cooling of the suspension to 4°C, 100
fjiCi of carrier free Na^^^I, neutralized with a few drops of
PBS, pH 7.4, was added. This was followed by addition of 20
jul lactoperoxidase (Sigma L-2130, 25 units/0.5 ml PBS), 10
^il glucose oxidase (Sigma G-8135, lmg/20 ml PBS) . The
reaction was allowed to proceed for 20 m with frequent
resuspension of the cells. Incorporation of into
protein was followed by periodically measuring the
trichloroacetic acid (TCA) insoluble ^25^ aliquots
of the reaction mixture. Each aliquot was added to 1 ml
PBS containing 1 mM potassium iodide (KI), then added to 1
ml of cold 10% TCA. The precipitate was immediately
filtered through a glass fiber microfilter (Whatman), and
washed with 50 ml cold 5% TCA. Radioactivity was measured
in a Beckman Gamma 5500 scintillation spectrometer.
At the termination of the reaction, the amoebae were
washed 3 times with cold PBS containing 5 mM KI and
processed for immunoaffinity isolation of radioactive
antigens.
^^S-Methionine incorporation.
Total E. histolytica proteins were labeled with ^^S-
methionine (Amersham) by addition of 10 /iCi/ml directly to
freshly inoculated amoeba cultures in TYI-S. The cultures
were grown to late log phase (approximately 48 h) and the
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amoebae were harvested in the usual manner. Total
incorporation was determined by TCA precipitation of
aliqouts of the cell lysate as above and counting in a
Beckman LS 7500 liquid scintillation spectrometer.
Gel drying and autoradiography.
After electrophoresis, gels were stained with Coomasie
blue and soaked with enhancer by rocking in a solution of
Resolution (EM Corp., chestnut Hill, MA) for 45 m at room
temperature. The gels were rinsed with cold water and then
dried in an LKB gel drier at 28 atm for 1 h. Membranes
were rinsed and dried on filter paper at room temperature.
Dried gels or membranes were exposure to Kodak XAR-5
film (Kodak diagnostic film X-Omat AR, Sigma) in cardboard
cassettes (Sigma) using Cronex intensifying screens (Dupont,
Wilmington, DL). The film was exposed at -85°C. The time
of exposure was varied and determined empirically.
Immunoprecipltation.
Pellets of radiolabeled amoebae were resuspended in 5
volumes of cold lysis buffer (50 mM Tris-HCl, 150 mM NaCl,
1% Triton X-100, 4 mM EDTA, 5 mM lAA, 0.2 mM TLCK, 0.2 mM
DIFP, pH 7.4), and vortexed for 4 m in ice. The lysate was
then centrifuged at 40,000 x g for 30 m at 4°C to remove
insoluble material.
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For precipitation of antigens to IgM itiAb, 100 fxl of
ascites fluid containing the IgM was mixed with 100 /il goat
anti-mouse IgM covalently bound to Sepharose 4B (Zymed) in
50 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.1% BSA, 0.05% NP 40,
pH 7.4 and incubated at room temperature for 1 h with
agitation in a Tomy MT 300 microtube mixture at setting 5.
Ascites fluid containing IgG MAb was treated similarly
using Protein G bound Sepharose 4B suspended in 50 jul of the
above buffer.
The suspension of antibody - antigen complex was then
transferred to a micropipet tip (Eppendof, Brinkmann
Institute Inc. Westbury, NY) plugged with glass wool. The
complex was washed with a total of 1.5 ml PBS, pH 7.4,
containing 1% Triton X-100. Washing was accomplished by
addition of successive 400 ^1 aliquots of wash buffer and
centrifugation of the pipet tip tube.
After washing, the gel was removed, mixed with 500 /il
of E. histolytica lysate containing radiolabeled proteins, and
incubated with agitation as above for 1 h at room
temperature. The gel was returned to the pipet tip column
and washed as above until no radioactivity was detected in
the eluate. The bound proteins were then eluted by
centrifugation of 75 /il of double strength SDS/PAGE sample




Protein concentration was detennined by the
bicinchoninic acid (BCA) method (Smith et al., 1985) using
reagents purchased from Sigma.
Microscopy.
Differential interference contrast (DIG) and
epifluorescence microscopy were done with a Zeiss Standard
16 microscope. Photomicrography was done using an Olympus
PM-10 photomicrography unit adapted for the Zeiss
microscope. Photographs were taken using Kodak Tri-X or
Tmax black and white film. All fluorescent images were
exposed for 2 s so that their relative fluorescence
intensity could be estimated.
CHAPTER IV
RESULTS
Characterization of anti-^. histolytica antiserum prepared in
rabbits.
Four weeks following the initiation of immunization,
the anti-£. histolytica antibody titer in the immunized rabbit
was approximately 2.6 X 10^, as determined by ELISA. A
booster of one-half antigen dose was administered at that
time and approximately 100 ml blood was drawn from the ear
vein 1 wk later. The titer was not increased further by
the booster.
IFA of the rabbit anti-£^. histolytica antiserum with
formaldehyde fixed whole /iwtofyftca trophozoites is shown in
Fig. 2. The surface of most cells stained brilliantly
(Fig. 2b), while little fluorescence was observed on the
surface of amoebae incubated with preimmune serum taken
from the same rabbit (Fig. 2d). The presence of antibodies
to surface antigens was further evidenced by the
agglutination of cells incubated with anti-serum, but not
of those incubated with non-immune serum (Figs. 2a and 2c,
respectively).
Fig. 3 shows the typical phagocytic and actin
polymerization responses of E. histolytica wpon contact with
human RBCs, a model mammalian target cell. Here,
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Fig. 2. Detection of anti-E. histolytica antibodies in
rabbit serum by agglutination and IFA. (a)
DIG of E. histolytica trophozoites, after
incubation with antiserum; (b) fluorescence
of the same cells, after incubation with
antiserum followed by fluorescein labeled
anti-rabbit immunoglobulin; (c) DIG of
E. histolytica trophozoites, after incubation with
non-immune serum; (d) fluorescence, after





Fig. 3. Phagocytosis of RBC by E. histolytica. Cells were
fixed 30 s following challenge with RBC. (a)
DIC; (b) fluorescence of the same cell





the amoebae were fixed 30 s after challenge at 37 °C with a
100-fold excess of target cells. Extensive phagocytosis of
multiple RBCs occurred (Fig. 3a). As the target cells were
drawn through the cortical actin layer they were ringed and
constricted by polymerized actin. This was revealed by
staining with rhodamine-phalloidin (Fig. 3b), which binds
specifically to polymerized actin.
Fig. 4a shows the inhibition of RBC attachment and
phagocytosis by rabbit anti-E. histolytica antiserum. This was
not quantitated, but was clearly evident by inspection of
the decreased number of target cells attached to the
amoebae incubated with antiserum compared to those
incubated with preimmune serum (Fig. 4b). Agglutination of
amoebae occurred in both experiments. In cells treated
with anti-serum, this was because of crosslinking by
surface bound antibodies. In the presence of nonimmune
serum, the amoebae were crosslinked by binding to target
cell ligands.
The typical pattern of polymerized amoeba actin
following challenge with RBC membrane liposomes is shown in
Fig. 4d. Because of the small size of the target vesicles,
distinct phagocytic "cups” (as form upon contact with whole
target cells) were not evident. Instead, the stimulated
amoebae showed a convoluted pattern of interconnected waves
of polymerized actin under the surface of the cells (Bailey
et al., 1987). Not all amoebae responded to the stimulus.
Fig. 4. Inhibition by rabbit anti-E. histolytica antiserum
of RBC attachment to E. histolytica trophozoites
(a, b) and of RBC membrane liposome
stimulated E. histolytica actin polymerization (c,
d). (a, b) Die of amoebae preincubated with
antiserum (a) and preimmune serum (b) before
challenge with RBC. (c, d) Rhodamine-
phalloidin stained amoebae preincubated with





The percentage of cells that respond provides the basis for
quantitation of the response (Bailey et al., 1987). In
this case over 50% of the cells treated with noninmiune
serum responded.
While the cortical polymerized actin layer of the
antiserum treated amoebae was clear (Fig. 4c), none of the
cells showed the polymerized actin patterns characteristic
of stimulated cells. Thus, the rabbit polyvalent anti¬
serum specifically blocked the amoeba cytoskeleton response
to target cell membrane liposomes.
Production of anti-E. histolyticamonoclonal antibodies.
Figure 5 shows the ELISA titration curves comparing
the immunogenic efficacy of the three forms of E. histolytica
antigen used to stimulate an antibody response in balb/c
mice. The maximum titer (approximately 3.9 X 10^) was
found in sera from mice immunized with whole amoebae
presented without adjuvant. However, the response in other
groups was nearly as high. The CDC personnel assisting in
the fusion experiments believed that the animal with the
highest overall response would provide greatest chance of
production of antibody producing hybridomas and requested
that this mouse be used. Therefore, in all the fusion
experiments mice from the group immunized with whole
amoebae in the absence of adjuvant were used.
Fig. 5. ELISA titration of antisera of balb/c mice
immunized with different preparations of
E. histolytica Results are means of
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Anti-E. histolytica antibody secreting hybridomas were
produced from three separate fusion experiments. Table 1
summarizes the results of these experiments and gives the
were detected. The results of the "blocking” experiments,
the determination of the ability of mAbs to inhibit
liposome stimulated polymerization of amoeba actin, are
also summarized in Table 1. In most cases, these
determinations were not made until later in the study using
ascites fluids and are described in a later section. The
results are included in this table for continuity.
Following the first fusion, 127 surviving
hybridization clones were detected in seven 24-well plates.
Supernatants from 30 wells of the initial plates were
positive by ELISA. Numerous wells contained more than one
distinct hybridoma colony. This fusion success rate
established that the experimental protocols were
satisfactory. Cells from the 10 wells giving the highest
ELISA titers were diluted and recloned into 96-well plates.
Unfortunately, when the first fusion was conducted,
the procedures were not yet perfected for mass screening of
hybridoma supernatants to detect surface reactive mAbs by
IFA. As the screening of subclones proceeded, it was
determined that many false positive results were being
obtained due to non-specific binding of fluorescent
secondary antibody. This led to erroneous interpretation
of the results and subcloning of hybridomas which
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Table 1 ■ Characterization of Anti-E. histolytica Monoclonal Antibodies.
mAb ELISA I FA Blocking Isotype
Fusion
GC6-CH2 + ? NT IgM
GC6-DC3 + ? NT igM
GC6-CD2 + ? NT IgG
GC6-CE2 + ? NT IgG
GC6-DF1 + ? NT IgM
GC6-DG1 + ? NT IgG
GC1-CA1 + ? NT IgG
GC1-BC1 + ? NT NT
GC1-BG1 + ? NT NT
GC1-BG3 + ? NT NT
I Fusion
CA6-BC3 + + + IgM
CA6-BC5 + + + IgM
CA6-CC3 + + + IgM
Fusion
DC6-AE11 + + + igG2a
DC6-CH1 + + + lgG2a
GA5-CH8 + + + lgG2a
GA5-AG4 + + + lgG2a
BC1-DA4 + - - IgG
BC1-CD1 + - - IgG
GA5-CE4 + - - IgG
GA5-ED8 + - - IgG
NT = Not tested
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subsequently were shown to be surface IFA negative.
Consequently, no useful mAbs were obtained from the first
fusion experiment.
From the second fusion, only IgM mAbs which were
surface IFA positive were detected. As experiments
proceeded with one of these IgM mAbs, complications in
attempts to identify its antigen by immunoblotting arose
(see below). Because of these problems, a third fusion was
conducted to seek IgG isotypes.
In the third fusion, only IgG producing
hybridomas were retained for subcloning. A total of eight
were retained. Of these, four were surface IFA positive.
The immunoglobulin classes of the mAbs were determined
by ELISA using commercial antibodies specific for mouse
IgA, IgM, IgGl, IgG2a, IgG2b, IgG3, kappa light chain and
lambda light chain following the procedures described in
Methods. The subclass assignments are shown in Table 1.
All of the IgG mAbs contained kappa light chains and were
the IgG2a isotype. The IgM mAbs contained lambda chains.
The system of itiAb designation followed by the
collaborating CDC laboratory was adopted to identify the
different mAbs. In this system the first 3 characters
identify the 24-well plate, row and well that contained the
original clone selected for sub-cloning in 96-well plates.
The second set of characters identifies the 96-well plate,
row and well from which the desired purified clone was
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finally isolated. Thus, CA6-CC3 was produced by a
hybridoma derived from 24-well plate C, row A, well 6 and
was finally isolated from 96-well plate C, row C, well 3.
As can be seen from their designations, all three IgM
mAbs isolated from the second fusion were derived from the
same well of the original 24-well plates. In the early
experiments to identify antigens to these IgM mAbs by
immunoblotting, no difference in the results obtained with
these three different antibodies was detected. Therefore,
it was concluded that they probably represented progeny of
the same initial hybrid clone. While ascites of all three
IgM mAbs were prepared, only CA6-CC3 was used (because of a
slightly higher titer in ascites fluid) for more detailed
study.
Similarly, the IgG mAb pair, DC6-AE11 and DC6-CH1 and
the pair, GA5-CH1 and GA5-AG4, were each derived from the
same well of an original 24-well plate and were the same
isotype. This raised the possibility that the members of
these two pairs also might be identical. Nevertheless,
studies were conducted with all four of these IgG mAbs.
All hybridomas have been cryopreserved and are stored
at the CDC. Cultures of hybridomas producing mAbs CA6-BC3,
CA6-BC5 and CA6-CC3 from the second fusion and DC6-CH1,
DA6-AE11, GA5-CH8, GA5-AG4 and the non-surface reactive
mAb, GA5-DA4, from the third fusion, were released to our
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laboratory for large scale production in mouse ascites and
further study.
Production of monoclonal antibodies in mice.
Monoclonal antibodies CA6-CC3, CA6-BC3, CA6-BC5, GA5-
CH8, GA5-AG4, DC6-AE11, DC6-CH1 and BC1-DA4 have been
raised in mice as described in the Methods section.
Approximately 20 ml each of mAb rich ascites fluid was
obtained for each mAb. After collection, these were
clarified by high speed centrifugation, distributed in 1 ml
aliquots and stored at -85°C. The ELISA titration curve
for each ascites preparation is shown in Fig. 6. Each mAb
had a titer of at least 10® in clarified ascites fluid.
Characterization of monoclonal antibodies by indirect
immunofluorescence assay.
Formaldehyde fixed E. histolytica were processed for IFA
without and with treatment with 1% Triton X-100. The
results are shown in Fig. 7. For all iiiAbs except BC1-DA4,
a bright ring of fluorescence was seen about the periphery
of cells not treated with Triton X-100. The peripheral
fluorescence of cells incubated with BC1-DA4 (Fig. 7k) was
no greater than that of cells not incubated with E. histolytica
specific primary antibody. In the detergent treated group
all mAbs, including BC1-DA4, showed fluorescent staining in
the interior of cells. The nucleus was evident as a
nonfIncrescent sphere in several photographs, further







Fig. 7. IFA of anti-E. histolytica mAhs. (a, c, e, g, i,
k) No detergent treatment; (b, d, f, h, j, 1)
treatment with Triton X-100 prior to
incubation with antibody. (a, b), CA6-CC3;
(c, d), DC6-CH1; (d, f), DC6-AE11; (g, h),
GA5-CH8; (i, j), GA5-AG4; (k, 1), BC1-DA4.





evidence of intracellular binding of the fluorescent
molecules in these cells.
The conclusion from these IFA experiments were that
all itiAbs tested, except BC1-DA4, bound to an antigen found
both on the outer surface of E. histolytica trophozoites and in
the cell interior.
Demonstration of capping of monoclonal antibodies.
Additional evidence that the mAbs isolated bind to the
surface of E. histolytica trophozoites was obtained by
demonstrating that these mAbs were capped when incubated
with live amoebae. To demonstrate capping of mAbs, live
amoebae were incubated separately with each mAb in culture
medium for 10 m. The cells were then rapidly washed 3
times with PBS, fixed, washed and incubated with
fluorescent secondary antibody. A distinct fluorescent cap
was observed on many cells with all the mAbs tested. A
typical result, that for mAb DC6-CH1, is shown in Fig. 8.
Stimulation of E. histolytica agglutination by monoclonal
antibodies.
Both live and fixed amoebae agglutinated into large
clumps when incubated with all mAbs except BC1-DA4. An
example of result using fixed amoebae is shown in Fig. 9.
The relative ability of each mAb to agglutinate fixed
E. histolytica as determined by agglutination titration. The
results are shown in Table 2. The surface IFA reactive
Fig. 8. Evidence for capping of bound mAb by
E. histolytica. Live amoebae were incubated with
mAb for 10 m, fixed and then stained with
fluorescein labeled secondary antibody.
Capping of DC6-CH1 is shown. Similar results
were obtained with all the surface reactive
mAbs.
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Fig. 9. Agglutination of E. histolytica hY surface
reactive itiAb. Fixed amoebae were incubated
with non-immune serum diluted 1:10 (a) or mAb
containing ascites fluid diluted 1:50 (b).
DC6-CH1 is shown as an example of the effect
of all surface reactvie mAbs.
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Table 2. Agglutination of E. histolytica by monoclonal antibodies.
Ascites fluid dilution
mAb 4 8 16 32 64 128 256
CA6-CC3 + + + + + +
DC6-CH1 + + + + + - -
DC6-AE11 + + + + + + -
DA5-CH8 + + + + + - -
DA5-AG4 + + + + + + -
BC1-DA4 + - - - - - -
Preimmune serum + — — — — — —
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mAbs were all about equally effective. They retained
adilutions over 100-times that of BC1-DA4, which was no
more effective than non-immune serum.
Inhibition by monoclonal antibodies of RBC membrane
liposome stimulated polymerization of amoeba actin.
The ability of the surface reactive mAbs selected for
study to inhibit liposome stimulated polymerization of
amoeba actin was tested with a range of dilutions of
ascites fluids. The results are shown in Fig. 10.
At dilutions up to 1:128 all amoeba surface specific
mAbs as well as polyvalent mouse antiserum against
/iwfo/yhca inhibited liposome stimulation over 60%. Several
mAbs and antiserum were tested up to a 1:512 dilution.
Even at this dilution inhibition was over 50% by all those
tested. All mAbs have been tested at least twice for their
ability to block target membrane vesicle stimulated
E. histolytica actin activation. Essentially the same results
were obtained in each experiment.
In contrast, another surface reactive itiAb (M3Ob;
Torian et al., 1988) provided to our laboratory by Dr.
Bruce Torian inhibited the amoeba actin response only 38%
at the highest concentration (1:4 dilution). Enough of
this antibody preparation was not available to complete the
titration of its inhibitory activity. At this same
dilution, preimmune mouse serum also showed some inhibition
Fig. 10. Titration of the ability of surface reactive
iiiAbs to block liposome stimulated E. histolytica
actin polymerization. The percent inhibition
was expressed as: 100 -(% stimulated in the
test assay -f % stimulated in the uninhibited
control). PBS replaced test serum or ascites
in the uninhibited control. The average
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of liposome stimulated cytoskeleton activation (about 25%)
compared to the control. This effect was lost upon further
dilution of the serum.
Cross reactivity of monoclonal antibodies.
Each mAb was tested for its ability to cross react
with Entamoeba invadens, a species of this parasite with
reptilian hosts, resembles E. histolytica closely in
morphology and behavior toward mammalian target cells
(Bailey and co-workers, unpublished observations). All
five surface reactive iiiAbs were tested for their ability to
recognize i«va<ie/ts trophozoites by IFA. Only CA6-CC3 gave
any indication of recognition (Fig. 11a). Curiously,
fluorescence was observed only in patches or regions of the
cell surface, never uniformly over the surface as with
E. histolytica. This was not due to patching of the antigen-
antibody complex, since the amoebae were fixed before being
exposed to primary antibody. The result obtained with all
of the IgG mAb isotypes is typified by Fig. 11b. The
intensity of fluorescence staining was not greater than
that seen in control experiments, in which non-immune serum
replaced the primary antibody.
Cross reactivity of CA6CC3 was also assessed by
immunoblotting against E. invadens, the bovine serum used
in E. histolytica culture medium, and three eucaryotic cells
types. These were cultured 3T3 cells. Friend
Fig. 11. IFA tests of cross reactivity of anti-
E. histolytica mAh with E.invadens. CA6-CC3 bound
in patches on the fixed E. invadens
trophozoites (a); none of the surface active
IgG mAbs, represented here by DC6-CH1 (b),




erythroleukemia cells and mouse liver cells. The results
with the eucaryotic cells are shown in Fig. 12. Those for
E. invadens are shown in Fig. 13. Only CA6-CC3 was tested
because only it gave an indication of cross reactivity by
IFA. No detectable cross reactivity was seen on
immunoblots against any of the cell types tested.
Interestingly, cross reactivity was inadvertently
detected against one of the prestained molecular weight
marker proteins, bovine RBC carbonic anhydrase, when this
was transferred to the blotting membrane (Fig. 13, lane
7) . Recognition of erythrocyte carbonic anhydrase by CA6-
CC3 was confirmed conclusively by blotting this itiAb against
purified commercial erythrocyte carbonic anhydrases A and
B. CA6-CC3 recognized both forms of the mammalian enzyme
(Fig. 14). These results suggested that RBC carbonic
anhydrase shared an epitopic structure with the antigen of
CA6-CC3 in E. histolytica.
This intriguing possibility was tested further by
preparation of rabbit antiserum to the purified commercial
erythrocyte carbonic anhydrase (Sigma) and determination of
the ability of this antiserum to cross react with E. histolytica
proteins. The results of this experiment are shown in Fig.
14b. A single well-defined band was detected at Mr 29,000,
detected in the regions of proteins bound by CA6-CC3.
Thus, while this experiment demonstrated that E. histolytica
possesses a protein analogous in size and immunogenicity to
Fig. 12. Immunoblots to detect cross reaction of CA6-
CC3 with proteins from several eucaryotic
sources. Ten /xg total protein was placed in
each lane. Lanes 1 and 2, E. histolytica lysate;
lane 3, 3T3 cell lysate; lane 4, Friend
erythroleukemia cell lysate; lane 5, mouse
liver lysate; lane 6, bovine serum. All
lanes were probed with CA6-CC3 at 1:2000
dilution.
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Fig. 13. Immunoblots to detect cross reaction of CA6-
CC3 with mvoi/em proteins. Lane 1,
E. histolytica lysate (stained on the membrane
with India ink); lane 2, E. histolytica lysate;
lane 3-5, E. invadens lysate (lane 3, 10 iiq;
lane 4, 15 ng; lane 5, 20 iig) ; lane 6,
molecular weight markers. CA6-CC3 was
diluted 1:4000, and AP conjugated anti-IgM
secondary Ab was diluted 1:200. No binding
to E. invadens proteins was detected by this
technique. Cross reaction to the molecular
weight marker, bovine erythrocyte carbonic
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Fig. 14. (a) Confirmation of cross reaction of CA6-CC3
with bovine erythrocyte carbonic anhydrase.
Lane 1, E. histolytica lysate; lane 2, bovine
erythrocyte carbonic anhydrase type A
(Sigma); lane 3, bovine erythrocyte carbonic
anhydrase type B (Sigma); lane 4, Sigma
molecular weight markers; lane 5, Diversified
Biotech, Inc. molecular weight markers.
Primary and secondary antibody dilutions were
as described for Fig. 13. (b) Cross reaction
of rabbit anti-bovine erythrocyte carbonic
anhydrase with E. histolytica proteins. Following
incubation with antiserum the membrane was
probed with ^25^ protein G (5 x 10^ cpm/ml)
and autoradiographed. Lane 1, 1:1000
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mammalian carbonic anhydrase, polyvalent antiserum
to the latter did not recognize the common epitope shared
by the E. histolytica of CA6-CC3 and this mammalian
enzyme. With the exception of the cross reactivity of CA6-
CC3 with carbonic anhydrase and possibly the surface of
E.invadens, the itiAbs against E. histolytica surfa.c& antigens
appeared to be highly specific for that species.
Identification of E. histolytica antigens by immunoblottinq.
Immunoblotting using enzyme labeled reagents to detect
mAbs bound to antigens on nitrocellulose membranes was the
first method used to attempt to identify the antigens to
the different mAbs that had been prepared. E. histolytica \ihole
cell lysates were prepared as described in Methods,
subjected to SDS PAGE under reducing conditions and
electrophoretically transferred to nitrocellulose
membranes. Alkaline phosphatase conjugated goat anti-mouse
IgM was used to detect the IgM mAb. Horseradish peroxidase
conjugated Protein A was used to detect IgG mAbs.
Results of a blot probed with varying concentrations
of mAb CA6-CC3 are shown in Fig. 15. Numerous protein
bands were detected. No bands were detected when the
primary antibody was omitted from the procedure, which
indicated that the bands resulted from the binding of mAb.
However, multiple bands were observed even at dilutions of
mAb of up to 1:16,000. Similar results were obtained in
Fig. 15. Immunoblots of dilutions of CA6-CC3 against
E. histolytica lysate. Lane 1, molecular weight
markers; lane 2, E. histolytica proteins stained
with India ink; lanes 3, primary antibody
omitted, lanes 4-9, E. histolytica proteins
probed with dilutions of CA6-CC3 decreasing
by one-half from 1:16,000 to 1:500. HRP
conjugated anti-IgM was used as secondary Ab
at 1:1000 dilution. While not visible on the
photograph, multiple bands were observed even
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numerous blotting experiments with CA6-CC3, using several
sources of anti-IgM labeled with both alkaline phosphatase
and with horseradish peroxidase.
One of several causes considered for these results was
that the specific antigen was a protein that interacted
nonspecif ically during electrophoresis with other E. histolytica
proteins. This could lead to detection of the antigen at
the sites of other protein bands on SDS gels. To test this
possibility, preparative isoelectric focusing, using the
BioRad Rotophor apparatus prior to SDS PAGE.
A total of 17 fractions were collected from the
apparatus. The pH of each fraction was measured and
aliquots of the odd numbered fractions were subjected to
SDS PAGE. These were then transferred to membranes and
probed with CA6-CC3. The results of one such experiment
are shown in Fig. 16. Again, detection of multiple bands
occurred, particularly at lower pH values. In the pH range
closer to neutral, fewer bands were seen. One of the more
prominent bands was seen at approximately Mr 48,000 in
lanes covering the pH range 4-7. Again, it was not
possible to identify a specific antigen using this
technique.
Blots probed with the IgG mAbs and HRP-Protein A are
shown in Fig. 17. While multiple bands were detected, the
most prominent of these was a diffuse band centered at
approximately Mr 48,000. Essentially the same binding
Fig. 16. Immunoblots of CA6-CC3 against E. histolytica
fractions resolved by lEF then by SDS PAGE.
Lanes 1-9, odd numbered lEF fractions
running from high to low pH; lane 10,
molecular weight markers. The blot was
probed with CA6-CC3 at a dilution of 1:4000




Fig. 17. Immunoblot of IgG itiAbs against E. histolytica
lysate. Lane 1, E. histolytica proteins stained
with India ink; lane 2, DC6-CH1; lane 3, DC6-
AEll; lane 4, GAS-CHS; lane 5, GA5-AG4.
Membranes were probed with mAb at 1:2000
dilution followed by HRP labeled Protein A at
1:500 dilution.
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profile was seen with all of the IgG mAbs. This
implied that they all recognized the same E. histolytica
antigen(s).
Additional experiments were conducted with similar results.
Binding to multiple bands was detected. However, the most
intensely stained band was usually in the region of Mr
48,000. Sometimes this band was broad; sometimes it was
well-defined.
Immunoblotting with labeled protein G.
Blotting to detect IgG mAbs bound to E. histolytica
proteins on nitrocellulose membranes was also done using
labeled Protein G. After transfer of E. histolytica
proteins from SDS gels, the membranes were incubated with
the same concentrations of IgG MAb as used in the blotting
experiments with enzyme linked secondary antibodies. After
washing, the membranes were incubated with 10® dpm/ml
labeled Protein G as described in the Methods section. The
membranes were autoradiographed. The results are shown in
Fig. 18.
As with the enzyme labeled Protein A reagent, all IgG
mAbs appeared to bind to the same antigen(s), and the most
prominent of these was located in a broad band centered
around Mr 48,000. However, a second diffuse band was seen
centered close to Mr 96,000. While faint for some mAbs,
this second band appeared in the lanes of all four of the
Fig. 18. Autoradiography of immunoblots of IgG mAbs
against E. histolytica lysate. Following
incubation with mAb, the membrane was probed
with 125j Protein G (5 x 10^ cpm/ml). Lane
1, DC6-CH1; lane 2, DC6-AE11; lane 3, GA5-





amoeba surface active mAbs. Bands at both Mr 48,000 and Mr
96,000 were commonly observed on other immunoblots of these
mAbs using this detection method (data not shown).
The possibility was considered that the Mr 96,000
antigen represented a dimer of the Mr 48,000 band, and that
this dimer was only partially dissociated by the detergent
and reducing conditions of SDS PAGE. To test this
possibility, immunoblots were conducted of proteins
transferred from SDS gels run under non-reducing conditions
(no mercaptoethanol treatment). The results of one such
experiment are shown in Fig. 19. The reactive bands
remained diffuse and still appeared at both positions. The
relative intensity of radioactivity was greater at the
higher molecular weight than when SDS PAGE was run under
reducing conditions. However, clear evidence was not
obtained that the antigen detected at Mr 96,000 represents
two Mr 48,000 dimers linked by disulfide bonds. However,
this possibility was not excluded.
Finally, this blotting procedure was used for 7% gels
run without either detergent or mercaptoethanol treatment
(native gel). A single immunoreactive band, which had
definitely, but barely, entered the running gel, was
detected (Fig. 20). Again, the same band pattern was
observed for all of the IgG mAbs tested. While Mr value
estimates can not be made from native gels, this result did
indicated that the native antigen of the IgG mAbs may be
Fig. 19. Autoradiograph of immunoblot of IgG itiAbs
against E. histolytica lysate resolved by non¬
reducing SDS PAGE on 7% gels. Other
conditions were as described for Fig. 18.
Lanes 1 and 6, mouse antiserum; lane 2,
primary Ab omitted; lane 3, DC6-CH1; lanes 4
and 8, DC6-AE11; lanes 5 and 7, GA5-CH8; lane
9, GA5-AG4. The band at approximately Mr
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Fig. 20. Autoradiograph of immunoblot of IgG mAbs
against E. histolytica lysate resolved by native
PAGE on 7% gels. Lane 1, primary Ab omitted;
lane 2, GA5-CH8; lane 3, GA5-AG4; lane 4,
DC6-AE11; lane 5, DC6-CH1. The position




part of a large protein aggregate. The possibility of
nonspecific interactions between proteins in the
detergent-free environment also can not be excluded.
There was also concern that ambiguous results,
including the poorly defined banding patterns, had been
obtained in these blotting experiments because of some
procedural error or artifact. That this was not the case
was verified by blots of mAb BC1-DA4 using pj-otein G
(Fig. 21). A single, well-defined band at approximately Mr
96,000 was obtained. This observation verified that the
immunoblotting procedures were satisfactory. Therefore,
the appearance of multiple or diffuse bands on blots of the
other mAbs was not an artifact of technigue. This must
have been related to a property of the mAbs themselves or,
more likely, of the antigens.
Immunoprecipitation.
Because of the failure to detect distinct and specific
protein bands on immunoblots of proteins from total amoeba
lysates separated by SDS PAGE, efforts were made to isolate
specific antigens by immunoprecipitation of
S-methionine labeled E. histolytica proteins.
Live amoebae were labeled with using the
lactoperoxidase/glucose oxidase method as described in the
Methods section. The amount of radioactive iodine bound to
amoeba protein was determined by TCA precipitation of a 10
Fig. 21. Autoradiography of immunoblots of BC1-DA4
against E. histolytica lysate. All lanes were
probed with BC1-DA4 at 1:1000 dilution
followed with protein G as for Fig. 18.
The band in each lane was at approximately Mr
96,000. The misalignment of bands in the
figure was a result of misalignment of
individual replicate membrane strips in the
autoradiography cassette.
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^1 aliqout of the reaction mixture and counting in the
gamma counter. In the initial experiments, the labeling
incubation was done at room temperature. Less than 10^ cpm
were incorporated per 10 ill sample under these conditions.
Control tests showed that all the reagents were active, and
incorporation using Protein A as a substrate for iodination
under the same conditions gave over 10^ cpm bound per 10 /il
of reaction mixture. When the iodination incubation
temperature was lowered to 5°^, the binding of
insoluble amoeba protein was greatly increased (Fig. 22).
Immunoprecipitation of labeled proteins.
An autoradiograph of labeled amoeba proteins
immunoprecipitated with CA6-CC3 mAb is shown in Fig. 23.
Three major bands were evident. These were at Mr 48,000,
Mr 40,000 and Mr 23,000. Immunoprecipitation of
labeled proteins with the IgG mAbs was not done.
Immunoprecipitation of ^^S-Methionine labeled proteins.
An autoradiograph of ^^S-Methionine labeled proteins
immunoprecipitated with the IgM mAb, CA6-CC3, is shown in
Fig. 24. The most intense bands appeared at Mr 48,000, Mr
40,000 and Mr 23,000, the same molecular sizes detected by
immunoprecipitation of labeled membrane proteins (Fig.
23). In this autoradiograph the radioactive labeling
profile of proteins in the total lysate (lane 1) shows
uneven labeling. An autoradiograph of S-methionine
Fig. 22 . Rate of incorporation of into








Fig. 23. Autoradiograph of labeled E. histolytica
proteins precipitated by CA6-CC3. The large
band at the bottom represents contaminating








Fig. 24. Autoradiograph of ^^S-methionine labeled
E. histolytica proteins immunoprecipitated by CA6-
CC3. Lane 1, total amoeba lysate before
immunoprecipitation (A more representative
radiograph is shown in Fig. 25.) '! lane 2,




labeled proteins iininunoprecipitated by the IgG itiAbs
is shown in Fig. 25. Interestingly, each of the IgG
antibodies gave essentially the same pattern. Furthermore,
the pattern resembled closely that of the proteins
precipitated by the IgM mAb, CA6-CC3. The most prominent
band was at Mr 48,000. Another strong band was at Mr
40,000, and a weaker band was at approximately Mr 23,000.
In addition there was a fourth, even weaker band, at
approximately Mr 32,000. This band was most clearly
evident for DC6-CH1 and DC6-AE11, but also visible on the
autoradiographs for GA5-CH8 and GA5-AG4. A protein at this
last position was never detected on autoradiographs of CA6-
CC3 immunoprecipitates and was usually not seen with IgGs.
The apparent similarity of antigen specificity of
CA6-CC3 and the IgG mAbs was tested by repeated
iinmunoprecipitation with CA6-CC3 and one of the IgG mAbs
(DC6-CH1) followed by electrophoresis of precipitates in
the same gel. The results are shown in Fig. 26 which
displays autoradiographs of duplicate gels of the same
immunoprecipitates. The patterns are similar for both
mAbs. Both precipitated a protein at the Mr 48,000
position. The secondary bands at Mr 40,000 and Mr 23,000
were less prominent. Another experiment, comparing the
proteins precipitated by CA6-CC3 with those precipitated by
the IgG, GA5-CH8, and analyzed on the same gel, gave
similar results, with the major band located at Mr 48,000
Fig. 25. Autoradiograph of ^^S-methionine labeled
E. histolytica proteins iminunoprecipitated by IgG
iriAbs. Lane 1, DC6-CH1; lane 2, DC6-AE11;
lane 3, GA5-CH8; lane 4, GA5-AG4; lane 5,
total E. histolytica lysate before
immunoprecipitation.
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Fig. 26. Duplicate autoradiographs of ^^S-methionine
labeled E. histolytica proteins immunoprecipitated
by CA6-CC3 and DC6-CH1. (a) Lane 1 and (b)
lane 2, DC6-CH1; (a) lane 2 and (b) lane 3,
CA6-CC3; (a) lane 3 and (b) lane 1, ^^S-
methionine proteins bound to the















(data not shown). On the basis of these comparisons, it
was concluded that all of the amoeba membrane reactive mAbs
under study recognized the same surface antigen(s). The
most distinct of these appeared to be a protein of
approximately Mr 48,000.
Confirmation of the efficacy of immunoprecipitation
procedures.
The efficacy of the immunoprecipitation procedures
used in the above experiments was established using an
eintx-E. histolytica ToKh that had been prepared and characterized
by Torian (1987). As stated earlier, this mAb, identified
as M3Ob, was kindly provided to our laboratory by Dr.
Torian. M30b does not recognize any E. histolytica protein on
immunoblots of SDS PAGE resolved E. histolytica proteins.
However, the mAb immunoprecipitates a Mr 96,000 protein
distinguishable on Coomasie blue stained gels (Torian,
1987) .
Fig. 27 shows the results of an immunoprecipitation
experiment with M3 Ob using the procedures and E. histolytica
lysates prepared in our laboratory. A distinct band at Mr
96,000 was evident on Coomasie stained gels. Gels of
immunoprecipitates obtained from another sample of the same
lysate using our IgG mAb, GA5-AG4, showed a very weak
E. histolytica protein band at Mr 48,000. It was clear that the
immunoprecipitation procedures employed in this study were
Fig. 27. Coomasie stained gels of E. histolytica proteins
precipitated by M3Ob and GA5-AG4. Lanes 1
and 2, immunoprecipitate of M30b; lane 3,
M30b itiAb alone; lane 4, molecular weight
markers; lanes 5 and 6, immunoprecipitate of
DA5-AG4. A faint band at approximately Mr
48,000 is visible in lanes 5 and 6 on




satisfactory. It was also evident that M3Ob was a much
more effective immunoprecipitant than was GA5-AG4.
Effect of periodate and Pronase treatment on monoclonal
antibody binding.
The possibility that one or more of the surface
reactive anti-E. histolytica mAbs was directed against a
carbohydrate moiety of a glycoprotein was tested by
treatment of amoeba lysate with periodate or Pronase. The
results are shown in Figs. 28 and 29, respectively.
Periodate significantly decreased binding of all
surface reactive mAbs but not for BC1-DA4, which bound to
an intracellular antigen. Binding of none of the mAbs was
decreased by the reactions conditions alone, if periodate
was omitted.
In contrast, Pronase only insignificantly decreased
binding of all of the surface reactive mAbs, except
possibly CA6-CC3, but completely abolished binding by BCl-
DA4.
In another experiment (data not shown) , E. histolytica
lysates resolved by SDS PAGE were transeferred to a
nitrocellulose membrane, and the membrane was then treated
with periodate. When probed with CA6-CC3 followed by HRP-
conjugated anti-IgM, no bands were detected. This implied
that carbohydrate was responsible for the binding of CA6-
CC3 observed on immunoblots of untreated proteins.
Fig. 28. Effect of periodate treatment of E. histolytica
lysate on ELISA of itiAbs. mAb dilutions
varied from 1:500 to 1:8500 in ELISA assays
depending on ascites titer. Untreated
control values were normalized to unit
activity. Treated values were calculated as
activity relative to the untreated control
for that experiment. Plotted values of
treated assays are means for 10 assays in 4
separate experiments ± SEM. Decreases in
activity caused by periodate were significant
at P < .01 for all mAb except DA4. The
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Fig. 29. Effect of Pronase treatment of E. histolytica
lysate on ELISA of mAbs. Conditions and data
presentation were the same as for Fig. 28.
The loss of activity with BC1-DA4 was
significant at P < 0.001. The loss of
activity with DC6-CH1 and CA6-CC3 was
significant at P < 0.05. Loss of activity









The basic objectives of this research were achieved.
The preliminary studies with rabbit anti-£. histolytica serum
demonstrated that antibodies which blocked E. histolytica
attachment and cytoskeleton response to target cell
membrane liposomes were generated and that the proposed
screening assays to detect mAbs with these properties were
feasible. The yield of mAb secreting hybridomas was
plentiful, and an abundant supply of several E. histolytica mAhs
was produced in mouse ascites fluids. Several of these
mAbs were shown to recognize antigens on the surface of
E, histolytica trophozoites, to be specific for this species,
and to block attack related responses of the amoebae.
The results of immunoblotting and immunoprecipitation
experiments implied that all five of the surface reactive
mAb studied were directed against the same antigen. The
bulk of evidence suggested that this was a molecule of
approximately Mr 48,000. However, in nearly all
experiments the mAbs bound to proteins of several molecular
sizes. Using periodate to selectively destroy sugar
residues, it was determined that these mAbs all seemed to
recognize carbohydrate epitopes, presumably attached to the
same amoeba membrane glycoprotein or proteins.
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In this chapter aspects of the results will be
discussed and interpreted.
Production of hvbridomas and monoclonal antibodies.
Whole E. histolytica trophozoites proved to be a potent
immunogen in both rabbits and mice. ELISA titers of over
10^ were obtained in both species. Considerable effort was
expended in preparing an amoeba membrane-rich fraction to
be used as a test antigen. It stimulated a total antibody
response nearly as high as that stimulated by whole cells.
The membrane fraction was undoubtedly contaminated with a
variety of intracellular antigens. However, the antisera
produced by this fraction may have been enriched in
antibodies to membrane antigens. Perhaps the best, if not
the only way to determine this would have been to produce
mAbs with spleens of mice immunized both with this antigen
and the whole cell antigen and then determine which
produced the greatest number of surface reactive mAb
secreting hybridoma clones. Due to the limitations of time
and resources available through the collaborating
laboratories at CDC, it was not possible to conduct this
comparison. At the request of CDC personnel the mice which
gave the highest total titer were used for all fusions.
Emulsification of antigen with Freund's adjuvant did
not enhance the antibody responses. Thus, special
conditions to obtain an antibody response in mice.
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In recent experiments using the facilities of the
newly established Biomedical Technology Service Laboratory
of the Morehouse School of Medicine, and using antigen
boosted mice from the original group immunized over a year
ago, two successful hybridoma productions have been
conducted. With the experience of the earlier mAb
productions, the more recent screenings to identify surface
reactive mAbs has progressed rapidly and smoothly. The
first fusion yielded over 15 anti-£'. histolytica antibody
producing clones. One of these, which produces a strongly
surface reactive mAb is being recloned. Screening by ELISA
and IFA of seven 24-well plates took less than one day.
Thus, this study has provided reliable procedures for our
laboratory to undertake production of large numbers of
E. histolytica xaKbs for further study.
Identification of surface reactive mAbs.
Binding of the isolated mAbs to outer plasma membrane
antigens of E. histolytica'was established by several criteria.
The principal criterion, upon which the initial selection
of surface reactive mAbs was based, was the characteristic
"bright ring" fluorescence pattern produced by IFA.
Using Triton X-100 to remove membrane lipids, the fixed
amoebae were made permeable to the large primary and
secondary antibody molecules. When this was done, antibody
binding of the surface reactive mAbs was observed not only
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to the outer surface of the cells, but also in the
cytoplasm. BC1-DA4, used as a control mAb for many of the
experiments, gave no indication of outer surface binding by
IFA. However, when cells were permeablized with Triton X-
100, a positive IFA, detecting internal antigens, was
observed with this mAb. Based on these tests, CA6-CC3,
DC6-CH1, DC6-AE11, GA5-CH8, GA5-AG4, but not BC1-DA4
appeared to be directed to antigens on the amoeba surface.
BC1-DA4 appeared to be directed against an exclusively
intracellular protein.
The observation that the antigens to the surface
reactive antibodies were found also in the interior of
cells was not surprising. Indeed, this is to be expected,
since all membrane proteins are synthesized and processed
within the cell. The epitope conformation recognized by
the itiAbs would arise at some point in the synthesis and
intracellular processing of the membrane antigens.
Furthermore, the plasma membrane is internalized
continually in motile cells during endocytosis (Aley et
al., 1984). In Entamoeba this is a particularly rapid and
active process (Aley et al., 1984). Entamoeba ts&ds
primarily by pinocytosis and phagocytosis. Both of these
processes involve internalization of vesicles surrounded by
plasma membrane. Matthews and co-workers (1987) studied
the distribution of E. histolytica membrane proteins by PAGE
analysis of different cellular fractions separated by
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differential centrifugation. They demonstrated that
essentially all of the plasma membrane proteins were also
detectable in intracellular fractions. Thus, the surface
antigen of E. histolytica detected by the several mAb prepared
in this study necessarily would be found in the interior of
the cell.
Capping of bound antibodies.
Capping studies gave additional evidence that CA6-CC3,
DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4 bound to the outer
surface of the cell, as well as information about the
functional behavior of the antigens to these antibodies.
E. histolytica is known to cap a variety of bound particles
including antibodies (Calderon et al., 1980), lectins
(Pinto da Silva, et al., 1975) and even whole target cells
(Bailey et al., 1985 and unpublished observations). The
process is rapid. A RBC bound at the head of an amoeba is
translocated to the tail at a rate of approximately 200
)Lim/s (Bailey, unpublished observations) . Thus, the bound
particle may traverse the length of the cell in about 20 s.
In the capping experiments conducted in this study,
live amoebae were incubated with mAbs for 10 m. If the
rate of membrane antigen translocation approximates that of
bound target cell movement, this was more than adequate
time for antigen-antibody complexes to accumulate at the
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cell uroid (tail). Indeed, this was the observation with
all the surface reactive mAbs.
Calderon et al. (1980) demonstrated that capped
antigen-antibody complexes were sloughed as vesicles from
the tail of live K/iwto/yrfca trophozoites into the medium.
Indeed, it has been suggested that the constant elimination
of bound antibodies by capping may represent one mechanism
by which this pathogen evades immunorecognition and
destruction in the host.
All the surface reactive mAbs agglutinated amoebae at
dilutions of ascites fluids up to 1:64. Conversely, BCl-
DA4, which bound only to an intracellular antigen by IFA,
failed to agglutinate cells at a dilution greater than 1:4,
the same as non-immune serum. Thus, the ability to
agglutinate cells provided further indication of which
antibodies bound to an outer membrane antigen.
Immunoprecipitation of labeled proteins.
^^^I labels outer plasma membrane proteins
specifically since the active reagent in this reaction can
not penetrate the cell membrane. The fact that
labeled E. histolytica proteins were immunoprecipitated by CA6-
CC3 implied that this mAb recognized antigens on the outer
surface of the cell. The additional evidence, from
immunoblotting and immunoprecipitation experiments, that
all of the surface reactive mAbs recognized the same
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antigen(s) allowed extension of this conclusion to include
all of the surface reactive mAbs.
In summary, a number of criteria were used to
establish that mAbs CA6-CC3, DC6-CH1, DC6-AE11, GA5-CH8,
and GA5-AG4 all bound to surface antigens of E. histolytica.
While it was important to use several criteria to establish
this point in this initial study, only one or two of the
tests would probably be sufficient in future screenings.
The simplest tests are the IFA and agglutination assays,
and these seemed fully reliable and discriminating.
Chemical nature of the antigens to anti-E. toro/vhcamAbs.
It was concluded that the epitope recognized by the
surface reactive mAbs is carbohydrate. The most compelling
evidence for this was the elimination of surface reactive
mAb binding by pretreatment of coated ELISA plates with
periodate. This test was repeated numerous times using a
reliable control (BC1-DA4) that demonstrated that the
effect of periodate was not artifactual. The loss of
binding capacity for all the surface reactive mAbs was
highly significant statistically. In a second type of
experiment nitrocellulose membrane blots of E. histolytica
lysate proteins were also treated with periodate. These
showed no bands when blotted with CA6-CC3 and HRP
conjugated anti-IgM, again demonstrating that periodate
destroyed antigenicity, at least for this mAb.
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Periodate destroys sugars with a gem-diol
configuration (-CH(OH)-CH(OH)-). Usually only the terminal
hexose of a glycoprotein or glycolipid glycan chain has
this sensitive configuration. However, destruction of this
single sugar frequently alters the epitope sufficiently to
destroy antibody recognition.
Pronase treatment only slightly reduced the ELISA
detection of the surface reactive mAbs. This must be
interpreted to mean that the carbohydrate antigen,
presumably an oligosaccharide of a membrane glycoprotein,
was able to bind to the plastic of ELISA plate wells in the
absence of the parent protein structure.
BC1-DA4, which recognized an intracellular antigen,
served as a control in these experiments. Its binding
activity was not affected by periodate, but was obliterated
by Pronase. Pronase hydrolyses essentially all of the
peptide bonds of any protein. SDS PAGE of E. histolytica
lysates after Pronase treatment gave no detectable Coomasie
staining except at the bottom of the gel, verifying that
this treatment destroyed all of the amoeba proteins.
The whole antigen molecule of the surface reactive
mAbs is most probably glycoprotein. The most compelling
evidence for this conclusion came from the
immunoprecipitation experiments using ^^s-
methionine. Both of these reagents are considered specific
for protein. i25j replaces to the para-OE of tyrosine
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residues in existing proteins, and ^^S-methionine is
incorporated into the peptide chain of newly synthesized
proteins during cell growth after it is added to the
culture medium. Both of these reagents labeled molecules
that were immunoprecipitated from E. histolytica lysates by the
mAbs. Thus, if the epitope is carbohydrate and the antigen
contains amino acids, it is a glycoprotein.
However, the possibility was considered that the
antigen might be a glycolipid that contained groups that
somehow became labeled by the radioisotopes, or was
attached specifically or non-specifically to a protein.
Normally, glycolipids run with the front on SDS PAGE.
However, there may be an immunogenic amoeba membrane
glycolipid that has such an affinity for amoeba protein
that it remained bound to proteins (specifically or non-
specif ically) even in the presence of SDS. While unlikely,
this possibility was tested by extracting E. histolytica lysates
repeatedly with chloroform:methanol (1:2 v/v), drying the
organic extract on the walls of glass tubes, and conducting
an ELISA assay in these tubes. No mAb binding was detected
by this method (data not shown). An additional experiment,
that should have been conducted but was not, was ELISA
assay of the protein residue after chloroform:methanol
extraction to be establish that the antigen activity was
retained in that fraction.
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Definitive evidence of the chemical nature of the
antigen to these mAbs will require its purification,
isolation and chemical analysis. Now, it seems most likely
that the antigen is a membrane glycoprotein.
Identification of specific antigens bv immunoblottina and
immunoprecipitation.
Progress in this research was retarded considerably by
the inability to detect easily a specific protein antigen
to each surface reactive mAb by the standard techniques of
immunoblotting and immunoprecipitation. The basic problem
was that multiple bands were almost always detected and the
banding patterns were not consistent from one experiment to
the next. Only by conducting many similar experiments and
using a variety of techniques was it possible to reach
conclusions with any confidence.
It was suspected that there may have been procedural,
errors which led to erroneous results. However, with some
antibodies (BC1-DA4, and anti-carbonic anhydrase on
immunoblots and M3Ob in immunoprecipitations), tested in
the same experiments, clear cut results were obtained. For
example, BC1-DA4, which did not bind to a surface antigen
gave a single, distinct band on immunoblots when detected
with 125j Protein G. CA6-CC3, which bound to numerous
proteins on blots of E. histolytica lysates, gave a clear band
when blotted against carbonic anhydrase, alone or as one of
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the protein molecular weight markers. Similarly, rabbit
anti-carbonic anhydrase gave a single sharp band when
blotted against complete E. histolytica lysate proteins.
The efficacy of the immunoprecipitation techniques was
clearly demonstrated using M3Ob, the antl-E. histolytica xaKt>
provided by Dr. Bruce Torian. This mAb was so effective
that the precipitated antigen could be detected readily on
Coomasie blue stained gels at the same Mr value reported by
Torian et al. (1987). On the same gel, one of the surface
reactive mAb used in this study, GA5-AG4, gave only a
slight indication of a precipitated protein, at
approximately Mr 48,000. Radiolabeling and autoradiography
of E. histolytica proteins was necessary before they could be
detected in immunoprecipitates using the surface reactive
mAbs and then multiple radioactive components were
invariably precipitated.
It was concluded that the difficulty in identifying a
single antigen to CA6-CC3, DC6-CH1, DC6-AE11, GA5-CH8 and
GA5-AG4 was due to the chemical properties of either the
antigens themselves or of the mAbs. Specifically, it was
probably related to the fact that the antigen contained
carbohydrate. By conducting a number of experiments
repeating patterns were observed in the immunoblotting and
immunoprecipitation. Collectively, the results that
allowed an interpretation of the molecular size and some
characteristics of the antigen to these surface mAbs.
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Interpretation of immunoblottina and immunoprecipitation
results.
Inmiunoblotting and immunoprecipitation evidence
indicated that CA6-CC3, DC6-CH1, DC6-AE11, GA5-CH8 and GA5-
AG4 all recognized the same E. histolytica eintxq&n. Whenever
these antibodies were analyzed together on the same blots
or on the same gels after immunoprecipitation, the same
banding patterns were observed. This was true also when
the immunoprecipitate of the IgM mAb, CA6-CC3, was compared
to that of one of the IgG mAbs. Thus, it was concluded
that all of the surface reactive mAbs were directed against
the same membrane glycoprotein(s).
In essentially all immunoblotting and
immunoprecipitation experiments mAb binding was detected,
and usually was most prominent, at approximately Mr 48,000.
This band was usually, but not always, diffuse. On
immunoblots of CA6-CC3 numerous other bands were always
detected. As a consequence, immunoblotting was abandoned
in favor of immunoprecipitation for this mAb.
On immunoblots of reducing SDS PAGE gels probed with
the IgG mAbs, DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4,
followed by either HRP-Protein A or ^^5^ protein G, the
most prominent band was broad and centered at Mr 48,000. A
second band was seen at about Mr 96,000 suggesting a
monomer-dimer relationship. When treatment with the
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sulfhydryl reagent was omitted, the band at Mr 48,000 was
still present. However, the band at Mr 96,000 appeared
relatively more intense than the Mr 48,000 band. Based on
these results, the possibility that the band at Mr 96,000
represented a dimer of two Mr 48,000 antigens (or a
heteropolymer containing one Mr 48,000 antigen and a
second, non-antigen, molecule of the same size) must remain
open.
When the mAbs were used to immunoprecipitate
radioisotopically labeled E. histolytica proteins, bands usually
appeared at Mr 40,000 and Mr 23,000 in addition to the band
at Mr 48,000 (and sometimes one at Mr 96,000). In one
experiment where the precipitates of the IgM, CA6-CC3, and
the IgG, DC6-CH1, were compared a minor band also appeared
at about Mr 32,000 with both itiAbs. These bands at
positions other than Mr 48,000 (and Mr 96,000) had not
appeared on immunoblots.
The interpretation of the differences in
immunoblotting and immunoprecipitation results was as
follows: The proteins represented by the bands at Mr
40,000 and Mr 23,000 were bound to the Mr 48,000 antigen in
the mild detergent lysates used for immunoprecipitation.
When the actual antigen, the Mr 48,000 protein, was
captured by the immunoprecipitating beads, the associated
proteins were captured indirectly. These proteins became
dissociated from the Mr 48,000 antigen by the SDS treatment
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prior to SDS PAGE and appeared as radioactive bands
corresponding to their own subunit molecular weights on
autoradiographs of the gels. When immunoblots were run,
SDS dissociated these protein complexes prior to PAGE. On
the blots, the itiAb bound only to the molecule containing
its epitope. Consequently, only the actual antigen was
detected on blots. By this interpretation, the proteins at
Mr 40,000, Mr 23,000 and possibly Mr 32,000 do not contain
a recognized epitope, but simply followed the true antigen
through the immunoprecipitation procedure.
Whether the binding of these additional proteins
represents a native association existing in live amoebae or
is the result of non-specific binding in lysates is not
known. However, it is noted that on native gels the
antigen barely penetrated 7% gels, indicating it was bound
to a larger complex of proteins. Also, it should be noted
that the proteins of Mr 40,000 and Mr 23,000 were labeled
by indicating that they existed on the surface of the
live amoebae during the period of isotopic labeling. These
data suggest that there may be several proteins in
association with the Mr 48,000 antigen within the membrane
of living amoebae.
The immunoblotting results are more understandable in
light of the finding that the antigen to the surface
reactive iiiAbs was a glycoprotein. Glycoproteins frequently
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give broad bands on gels and immunoblots due to the
variability of the structures of the carbohydrate moieties
and their chemical properties. A good example is the broad
banding of the membrane glycophorins of erythrocytes on
PAGE gels. Similar results have also been found on
immunoblots of leukocyte membrane antigens. Furthermore,
the variability of banding patterns found in immunoblotting
and immunoprecipitation experiments run with E. histolytica
lysates prepared on different occasions may reflect
differences in the distribution of the carbohydrate
antigens among cell proteins in different cultures or at
different stages in cell growth. Virtually nothing is
known about the biochemical variability of E. histolytica as a
function of growth stage in laboratory cultures. There is
also evidence of genetic variation that may arise over
extended periods of axenic culture of this organism.
Either of these factors might lead to variability of
surface glycoprotein composition. While not documented
explicitly, it was noted that a single lysate yielded the
same immunoblotting or immunoprecipitation patterns if run
a second time. This implies that the variability noted was
more a function of the biochemical status of the amoebae at
the time of harvest than of the conditions of subsequent
immunochemical analysis.
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In IFA experiments conducted recently by Mr. Norman
McCoomer in our laboratory using the surface reactive mAbs,
it has been noted that different surface banding patterns
occur on cells from the same culture. These have been
divided into three categories: heavy stained cells;
moderately stained cells; and unstained cells. He is
currently conducting experiments to determine whether this
observation is an artifact of experimental technique, the
result of differences in cell age or biochemical status in
culture or, possibly, actually represents variability in
the expression of glycoproteins on the surface of cells in
the same culture. If the last turns out to be the case,
this might explain the variability of immunochemical
analysis observed in this study and could be of
significance to the survival and pathology of E. histolytica in
human hosts.
Cross reactivity.
Regardless of the possibility that there may be
recognition of more than one antigen within E. histolytica, all
of the IgG mAbs appeared to be highly species specific. No
evidence was detected of cross reactivity with E. invadens or
proteins from several mammalian species.
The same was not true of CA6-CC3. In fact, the
binding specificity of this mAb was difficult to interpret.
CA6-CC3 cross reacted weakly with the surface of E. invadens.
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This might indicate that the carbohydrate epitope
recognized by this mAb existed also on the surface of the
reptilian parasite. However, this mAb also recognized
mammalian carbonic anhydrase, a small protein of known
structure which lacks attached sugars. Equally confusing
was the observation that rabbit anti-carbonic anhydrase
anti-serum, while recognizing a protein in E. histolytica, did
not bind to the same amoeba antigen as did CA6-CC3. If
CA6-CC3 recognizes a conformation on carbonic anhydrase
that is shared by its E. histolytica antigen, why did the
polyvalent antiserum, which should have contained
antibodies against all immunogenic conformations of the
mammalian enzyme, not recognize this shared epitope of
E. histolytica? Also, why did CA6-CC3 bind to both carbohydrate
and amino acid epitopes. Possibly this is simply a mAb of
low specificity. However, if this is so, one would have
expected a broader range of cross reactivity with other
systems. An alternative answer is that the E. histolytica
epitope recognized by CA6-CC3 is a conformation comprised
of both carbohydrate and amino acid moieties. This notion
is supported by the observation that treatment with both
periodate and Pronase significantly decreased CA6-CC3
binding activity. In carbonic anhydrase, CA6-CC3 finds a
conformation that resembles the amino acid portion of this
epitope and is able to bind. The rabbit antibodies.
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however, can not bind only to this portion of the epitope
on the E. histolytica eint.Lqen.
It should be noted that while both CA6-CC3 and the IgG
mAbs recognized carbohydrate epitopes, there was no
evidence that they recognized the same epitope. Demonstration
of a protein in E. histolytica that cross reacts with antibodies
to mammalian carbonic anhydrase and has the same molecular
weight as the eucaryotic enzyme provides the first evidence
for the existence of this protein in E. histolytica and its
structural resemblance to the eucaryotic enzyme. The
question of the existence and role of carbonic anhydrase
activity in E. histolytica is now being addressed by Dr. Gordon
Leitch in the Department of Physiology of MSM. The
findings in the present study will provide the basis for a
collaboration with his laboratory to investigate the
structure and role of carbonic anhydrase in E. histolytica.
The laG mAbs. DC6-CH1. DC6-AE11. GA5-CH8 and GA5-AG4. mav be
identical.
There is a distinct possibility that the IgG mAbs are
all identical. They were all the same isotype and
comprised two pairs each of which were derived from the
same original well of a 24-well plate. No significant
difference was observed in the immunoblotting or
immunoprecipitation patterns generated by these four mAbs
when compared on the same gel and with the same E. histolytica
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lysate. Also, no difference in cross reactivity of these
mAbs with other proteins or species was observed.
The yield and titer in ascites fluids did vary among
the IgG mAbs, and there was some difference in the degree
of effect of periodate and Pronase among the group.
However, the differences in antibody production in ascites
could easily be explained by other factors. The
variability in the effect of periodate on mAb binding could
also have been the result of variability in the
effectiveness of this reagent in different experiments.
Certainly, it would not be possible to conclude solely on
the basis of these differences that the IgG mAbs
represented different idiotypes with different epitope
recognition sites. At this time there is no evidence to
suggest that DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4 are not
the same.
mAb inhibition of E. histolytica attacV: response.
CA6-CC3, DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4 all
inhibited the E. histolytica attack response as represented by
target cell membrane liposome stimulated actin
polymerization. Preimmune serum and another surface
reactive mAb, M3Ob, did not have this effect. This
indicated that the mAbs prepared in this study interacted
with a degree of specificity in blocking this response.
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To date the only E. histolytica membrane protein known to
play a role in the attack mechanism is the Gal/GalNAc
lectin (Ravdin, 1989). This protein has been purified. It
is a Mr 220,000 dimer comprised of Mr 170,000 and Mr 35,000
subunits (Petri et al., 1989). This protein also has
carbohydrate attached (Petri et al., 1987). However, based
on the differences in molecular size there is little
likelihood that the mAbs isolated in the present study bind
to this protein. At this time one can only speculate on




1. Procedures were developed for the preparation and
identification of anti-E. histolytica monoclonal antibodies that
bound to the parasite plasma membrane surface and blocked
target cell membrane stimulated liposome actin
polymerization.
2. Hybridomas were grown from three fusion experiments.
After recloning, six mAbs were produced in mouse ascites
fluids for further study. These included one IgM mAb,
designated CA6-CC3, and five IgG2 isotypes, designated
DC6-CH1, DC6-AE11, GA5-CH8, GA5-AG4 and BC1-DA4.
3. Using indirect immunofluorscence, agglutination and
capping assays and immunoprecipitation of labeled
E. histolytica proteins, it was established that CA6-CC3,
DC6-CH1, DC6-AE11, GA5-CH8, GA5-AG4 all bound to antigens on
the outer surface membrane of amoebae. BC1-DA4 bound to an
intracellular antigen.
4. Binding by the surface reactive mAbs was destroyed by
periodate treatment of coated ELISA wells or immunoblot
membranes, indicating that the epitope of these antibodies
'was a carbohydrate. Binding of CA6-CC3 was also inhibited
by Pronase, suggesting that this mAb may also recognize
amino acids as part of the epitope. BC1-DA4 binding was
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unaffected by periodate but destroyed by Pronase, indicating
that this mAb recognized a purely peptide epitope.
5. The surface reactive IgG itiAbs showed no cross
reactivity with the reptilian parasite. Entamoeba invadens, or
with proteins from several mammalian cell types. It was
concluded that the IgG mAbs were specific for E. histolytica.
6. CA6-CC3 cross reacted weakly with E. invadens hy IFA but
not on immunoblots. CA6-CC3 also cross reacted with bovine
erythrocyte carbonic anhydrase, a non-glycoprotein, but not
other mammalian proteins tested. Rabbit anti-erythrocyte
carbonic anhydrase was prepared and found to recognize a
single protein band of E. histolytica on immunoblots (with the
same Mr as the mammalian enzyme), but did not bind at the
any of the positions detected by CA6-CC3. It was concluded
that CA6-CC3 may be a mAb of relatively low antigen
specificty, or may have an epitope with both carbohydrate
and peptide portions.
7. CA6-CC3 bound to numerous E. histolytica, proteins on
immunoblots. DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4 all
bound principally and diffusely to an Mr 48,000 band on
immunoblots. Antigenicity was also detected at Mr 96,000,
suggesting that the Mr 48,000 antigen formed dimers. The
antigen of BC1-DA4 was a single Mr 96,000 protein.
8. Amoeba proteins were labeled enzymatically with
and metabolically by ^^S-methionine and immunoprocipitated.
While multiple bands were detected, the prinicpal band was
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at Mr 48000. The Mr 48,000 antigen co-precipitated with
proteins of Mr 40,000, 32,000 and 23,000 suggesting that the
smaller peptides bind specifically or non-specifically to
the Mr 48,000 antigen in cell lysates. 8. No structural
or antigen recognition differences were found between the
IgG mAbs, DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4. It was
concluded that these may be identical.
9. CA6-CC3, DC6-CH1, DC6-AE11, GA5-CH8 and GA5-AG4 all
blocked target cell membrane liposome stimulated E. histolytica
actin polymerization at dilutions up to 1:128. BC1-DA4 and
another surface reactive mAb, M3Ob, provided by Dr. Bruce
Torian, did not inhibit this attack related response. It
was concluded that the surface reactive mAbs isolated in
this study interacted specifically with a membrane
glycoprotein that was involved in the mechanism of E. histolytica
attack upon mammalian target cells.
In summary, methods have been developed and applied to
identify and prepare mAbs against membrane antigens of
E. histolytica that are involved in attack of the parasite on
mammalian cells. Using several mAbs with the same antigen
specificity, an amoeba membrane glycoprotein of Mr 48,000
was detected. An E. histolytica antigen of this size and with
these properties has not previously been reported. Its
further study should provide useful information concerning
the mechanism of E. histolytica cytopathogenicity.
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